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1CHAPTER ONE
LITERATURE OVERVIEW
Spore Structure and Environment of Spores
In response to a lack of nutrients or environmental stress, a variety of species
belonging to the phylum Firmicutes produce endospores (or spores). All known spore-
forming species are members of Bacilli, Clostridia, Erysipelotrichia, and Negativicutes
classes [1]. The best studied species are members of Bacillaceae. A spore is a dormant
cell that protects the bacterial genome. The basic design of a spore is similar across
bacterial species. A spore is made out of concentrically arranged layers [2]. The inner
most compartment is the core which houses the bacterial DNA. The core is surrounded
by an inner forespore membrane, then a germ cell wall which is enclosed by a
peptidoglycan layer, called the cortex. The cortex is encompassed by an outer membrane
which is encircled by the coat. The coat is composed of a few layers and the number of
layers varies depending on the species. Core, cortex and coat are three essential structures
that provide protection [3]. Interestingly, the coat is not always the outer most shell. In
fact, some species have an additional layer called the exosporium. This layer is separated
from the coat by the interspace. The exosporium is made out of the inner basal layer and
the outer layer. The outer layer is made out of nap of hair-like projections [4]. Examples
of bacteria that possess the exosporium are: Bacillus thuringiensis, Bacillus megaterium
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and Bacillus anthracis. On the other hand, species of bacteria whose spore lack the
exosporium are Bacillus subtilis, Bacillus licheniformis and Bacillus clausii. This striking
dissimilarity among bacteria raises the question of why the microorganisms would differ
in their outer appearance. It is interesting because species with and without the
exosporium can be found in the same environmental niches. For example, in one study, it
was shown that species with the exosporium (Paenibacillus polymyxa, Bacillus
megaterium and Bacillus cereus) as well as species without the exosporium (Bacillus
pumilus) are commonly found in the rhizosphere of wild barley [5]. An even a more
complex mixture of both types of spores was shown by Barbosa et al; where spores with
the exosporium (Bacillus megaterium, Paenibacillus alvei, Bacillus cereus, Brevibacillus
brevi and Brevibacillus laterosporus) and without the exosporium (Bacillus pumilus,
Bacillus subtilis, Bacillus licheniformis and Bacillus amyloliquefaciens) were rescued
from the feces of broilers [6]. Additionally, Bacillus licheniformis, Bacillus pumilus,
Bacillus circulans, and Bacillus subtilis were found together with Bacillus cereus group
members in multiple samples of pasteurized milk [7]. The observation that various spores
are found in the same environment suggests that all dormant cells have to face the same
external challenges. For example, many spore-forming bacteria reside in the soil. In this
environment, spores are in contact with, and attach to, the soil components. Moreover,
spores found in the same environment are subject to water and humidity changes. Since
the coat and the exosporium are the outer most layers, it is intuitive to speculate that both
of them have similar structures to perform related functions. This reasoning led to the
question of my research: despite the differences in the outer layers among the bacterial
species, is there a protein that commonly appears on the outside of a spore?
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BclA: Domain Architecture and Function
To answer the question whether there is a universal spore surface marker, we chose a
well characterized protein called BclA. This protein is present in B. anthracis, B. cereus,
B. thuringiensis and other closely related species (so called B. cereus group). BclA is the
immunodominant protein in B. anthracis [8, 9]. BclA (bacillus collagen-like protein of
anthracis) is a glycoprotein that was first discovered on the surface of B. anthracis spores
[8]. It has been shown that BclA is absent in vegetative cells and only found on spores.
BclA is the major component of the hair like nap that protrudes from the basal layer of
the exosporium in B. cereus group species. Recently, BclA has been also found on the
spore surface of Clostridium difficile. This finding is surprising because C. difficile does
not possess the exosporium. Furthermore, C. difficile is not related to B. cereus group. In
fact, C. difficile belongs to Clostridiaceae. The discovery that BclA is found on the spore
surface of species from two different families made it plausible to think BclA might be a
common spore protein. BclA contains three major regions: an N- terminal domain that
anchors the protein to the basal layer [10] a region of GXX collagen-like repeats (CLR),
and a C-terminal domain which is the immunodominant part of the protein (Figure 1).
The N- and C-termini are relatively conserved whereas the collagen-like region varies
across B. anthracis strains [11]. The crystal structure of the C- terminus resembles the
C1q domain from the complement, which is a member of the TNF superfamily [12]. It is
worth noting the resemblance is at the level of the three dimensional structure, not the
amino acid sequence. The function of BclA is still unclear. Sylvestre et al. showed BclA
is not required for resistance to lysozyme or proteinase K [8]. Moreover, spores that
lacked BclA were similarly resistant to treatments with 100 mM hydrogen peroxide, 0.5
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M hydrochloric acid, 0.5 M sodium hydroxide, 10% toluene, and 100% methanol [8].
Also, Bozue et al. showed the lack of BclA did not affect the virulence of the spores in
animal models using several challenge methods [13]. However, Oliva et al. showed, the
recognition of BclA promotes spore uptake by phagocytes which facilitates transport of
the spores to the site where they germinate [14]. This interaction contributed to the
mortality of mice as the lack of the receptor that recognized BclA corresponded to the
increase survival of the animal.  Gu et al. reported BclA is important for the classical
complement pathway activation where it recruits C1q to the spore surface. This is
followed by spore phagocytosis by macrophages [15]. The possible function of BclA may
be linked to its interaction with the environment.  It has been noted that spores lacking
the protein germinate faster and are less hydrophobic than the wild type spores [16]. A
different result was presented by Lequette et al. who looked into the role of BclA in B.
cereus spores. Loss of BclA made the spores more hydrophobic [17]. It was also shown
the spores lacking BclA on their surface had a reduced interaction with stainless steel.
The author claims that the adherence properties of B. cereus which lacks BclA are
lowered and consequently spores get detached easier from the surface. In another study,
Chen et al, reported spores lacking BclA on their surface were more adhesive than the
wild type spores [18].
Differences between the Coat and the Exosporium
It is important to consider the difference between the coat and the exosporium when
determining whether BclA is present in both of these layers. The coat is composed of
approximately 70 different proteins in B. subtilis [3]. The exosporium is composed of
about 20 proteins and glycoproteins as well as lipids and carbohydrates [9, 19 and 20].
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Most of the proteins found in the exosporium are specific to that layer except for three
proteins whose orthologues are found in the coat of B. subtilis –CotB, CotY and ExsY
[20, 21]. Because the coat and exosporium are two distinct structures, one would expect
BclA would be incorporated differently in spores that have the exosporium. We have
some knowledge of how BclA is incorporated into the exosporium of B. anthracis. In
order for BclA to assemble around the entire spore surface, BxpB (also called ExsFA)
protein is required [22, 23, and 24]. A conserved motif in the N-terminal domain of BclA
is required as well. Based on BLAST, BxpB is only present in species belonging to the B.
cereus group. If BclA is present in spores lacking an exosporium, then it will be anchored
to the coat in a different way than in species that have an exosporium. Consequently, I
expect to see novel N-terminal domain sequences in various species. The support for my
expectation comes from the knowledge that BclA is present on the spore surface of C.
difficile which seem to lack BxpB protein (BLAST). This means there must be an
alternative mechanism which anchors BclA to the spore surface. In B. subtilis, I expect
BclA to interact with one or more of the outer coat protein or crust proteins. There are 24
proteins that are found in the outer coat of B. subtilis [25]. It is possible that BclA would
interact with the most abundant proteins of the outer coat – CotB, CotG or CotC [21].
Additionally, we need to consider that BclA might interact with CotX/CotY/CotZ or
CotW which are the crust proteins [McKenney 26]. If we find BclA in B. subtilis, we will
consider looking for the protein in closely related species. B. subtilis, B.
amyloliquefaciens, B. methylotrophicus, and B. atrophaeus belong to the Subtilis clade
[27]. I would hypothesize that closely related species have homologous proteins that
make up the spore.
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The fact BclA is found on the spore surface of C. difficile lets us speculate the protein
may be found on the spore surface of species belonging to other families harboring spore-
forming bacteria besides Bacillaceae and Clostridiaceae. We know members of
Paenibacillaceae include spore-forming bacteria. Spore formers are found in
Aneurinibacillus, Paenibacillus and Brevibacillus genera. I am curious to explore
whether BclA is present in any of the species from Paenibacillaceae.
Figure 1. Domain organization of BclA protein.
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METHODS AND MATERIALS
Strains and Media
Bacterial species and strains used in this study are listed in Table 1.  Spores were
prepared by exhaustion in Difco Sporulation Medium (DSM) [28]. A single colony was
picked from a Luria Broth (LB) plate and suspended in 200 µl of DSM. The bacterial
suspension was spread onto a DSM plate and incubated at 37 °C for 8 to 9 hours. After
the incubation period, the lawn was collected by suspension in 5 ml of DSM. 1ml of the
lawn was transferred into the 35 ml of DSM in a 250 ml flask. The flask was shaken at
225 rpm / 37 °C overnight. The next day, 5 µl of the sample was placed onto a glass slide
and the sample was checked for the presence of spores under the phase-contrast
microscope. Spores were spun down and pellets were washed 3 times with Milli-Q water.
Spores were stored in water in 50 ml tubes at 4°C.
Escherichia coli strains were cultured in LB medium. Antibiotics were added when
appropriate: 100 µg/ml spectinomycin, 100 µg/ml erythromycin, 100 µg/ml ampicillin,
and 15µg/ml chloramphenicol. Plasmid DNA was isolated using the ThermoScientific
Gene JET Plasmid Miniprep Kit (Lithuania), and genomic DNA was isolated with the
Promega Wizard Genomic DNA Purification Kit (Madison, WI).
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Construction of Mutant Strains
Plasmids were introduced into bacterial cells by conjugation [29]. On day 1, the donor
strain, the recipient strain and the helper strain were streaked out onto LB +100 µg/ml
spectinomycin, BHI, and LB +100 µg/ml ampicillin respectively. The donor strain
contained the allelic exchange construct cloned into pRP1028. The recipient strain was
either B. atrophaeus 1942, B. subtilis BSn5, B. subtilis PY79 or B. anthracis. Plates were
incubated at 37°C overnight. On day 2, each strain was scraped off the plate, plated onto
a BHI plate, and mixed together. The plate was incubated at the room temperature. On
day 3, the mixed strains were streaked out onto a selective plate that contained BHI + 250
µg/ml spectinomycin + 60 units/ml polymixin B. The plates were left at the room
temperature for 48 hours.
Bacteria were transformed by electroporation [29]. A single colony was suspended in
3 ml of BHI containing 0.5% glycerol and incubated at 37°C with shaking at 225 rpm
overnight. The next day, 0.2 ml of an overnight culture was transferred to 25 ml of BHI
containing 0.5% glycerol in a 250 ml flask and incubated at 37°C with shaking at 225
rpm. At OD600 of 0.8, cells were harvested by spinning down at 3000 rpm or alternatively
by filtering, washed twice with 25 ml of ice-cold electroporation buffer (1 mM HEPES,
10% glycerol, pH 7.0). The cells were resuspended in electroporation buffer to 1/20 of
the original volume. 5 µl of plasmid DNA was mixed with 0.2 ml of the cell suspension
on ice in a cooled 0.2-cm-gap electroporation cuvette. The cells were exposed to a single
pulse at 2.5 kV, 25 uF, and 200 Ohm (time constant of 4-5 msec). After the pulse, the
cells were transferred to a sterile tube containing 1 ml of BGGM (BHI with 10%
glycerol, 0.4% glucose, and 10 mM MgCl2). Samples were incubated with shaking at 225
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rpm for 2-3 hours at 28 °C. The samples were plated on LB plates with 100 µg/ml
spectinomycin and incubated at the room temperature for 48 hours.
An alternative electroporation protocol was used based on Xue’s work [30]. A single
colony was suspended in 5 ml of LB and incubated at 37°C at 225 rpm overnight. 0.6 ml
of the overnight culture was transferred to 10 ml of LB + 0.5 M sorbitol in a 250 ml flask
and incubated with shaking at 225 rpm. At OD600 of 0.9, the cells were harvested by
spinning down at 5000 rpm and washed four times with 10 ml of ice-cold electroporation
buffer (0.5 M sorbitol, 0.5 M mannitol and 10% glycerol). The cells were resuspended in
electroporation buffer to 1/20 of the original volume. 5 µl of plasmid DNA was mixed
with 0.2 ml of the cell suspension on ice in a cooled 0.2-cm-gap electroporation cuvette.
The cells were exposed to a single pulse at 2.5 kV, 25 uF, and 200 Ohm (time constant of
4-5 msec). After the pulse, the cells were transferred to a sterile tube containing 1 ml of
the recovery medium (LB + 0.5 M sorbitol + 0.38 M mannitol). Samples were incubated
with aeration for 2-3 h at 28 °C. The samples were plated on LB plates with 100 µg/ml
spectinomycin and incubated at the room temperature for 48 hours.
The third electroporation protocol was based on Zhang’s study [31]. The adjusted
protocol was based on Xue et al. work with some modifications: at OD600 of 0.5, 1%
threonine and 0.07% Tween 80 were added to the growing cells. Additionally, the field
strength was increased to 20,000 KV/cm by using 0.1-cm-gap electroporation cuvette at a
single pulse at 2.5 kV, 25 uF, and 200 Ohm.
Bioinformatics
Amino acid sequences of bclA genes were obtained from the National Center for
Biotechnology Information (NCBI) database.
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Molecular and Genetic Techniques
First, gfp carrying plasmid was built. The gfp was amplified from pUTE-gfp using
High Fidelity Platinum Taq polymerase (Invitrogen). Amplified PCR product had A-
overhangs and was ligated into pGEMT (Promega). pGEMT-gfp was digested with KpnI
+ SacI and ligated into pRP1028. pRP1028-gfp was digested with SacI and PmeI and
bclA fragment with SacI and EcoRV. bclA alleles were amplified by Polymerase Chain
Reaction (PCR).  Primers are listed in Table 2. The PCR products were digested with
Eco321 and SacI and cloned into pRP1028 which was digested with SacI and PmeI. The
pRP1028 construct was used to transform E. coli DH5α. This plasmid was passed
through E. coli JM110 as well.
Spore Surface Protein Extraction and Western Blot
Chemical extraction of coat proteins was performed. Proteins were extracted from
each bacillus species listed in Table 1 [32]. 50 ml of spores were pelleted down and
resuspended in 10 ml of water. 5 µl of spore suspension was mixed with 495 µl of water
and OD600 was measured and recorded. The formula 0.037/ OD600 was used to estimate
the amount of spore suspension needed for each well. The appropriate amount of spore
suspension was pelleted for 5 min/6000 rpm and the supernatant was removed. 13 µl of
Laemmli buffer (0.63 ml 1M Tris pH 6.8, 1 ml 100% glycerol, 2ml 10% SDS and 6.37
ml MQ water) and 1.5 µl of 1M DTT were added to the pellets. The samples were
vigorously shaken for 1 minute and spun down for 2 seconds. The samples were boiled
for 5 minutes at 100 °C. The samples were shaken again for 45 seconds and boiled at
100°C for an additional 5 minutes. The samples were vigorously shaken for 30 seconds
and spun down for 5 minutes at 13000 rpm. The supernatants were collected and the
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protein concentration was measured with Nanodrop. Proteins were resolved on 15%
SDS-PAGE (10% 29:1 acrylamide: N, N’-methylene-bis-acrylamide, 375 mM Tris pH
8.6, 0.1% SDS), at100 µg/100 µl concentration, and transferred to polyvinylidene
difluoride membranes or nitrocellulose membranes [33]. The membranes were incubated
with 2% bovine serum albumin (BSA), washed three times with Tris-buffered saline with
Tween 20 (1x TBST: 1.21 g Tris, 8.76 g NaCl, 0.05% Tween 20 in 1L of water) then
incubated with monoclonal anti BclA antibody (BA-MAB 5; Critical Reagents Program,
Department of Defense) or polyclonal antibodies (anti-BclA antiserum, non-immune
serum or serum coming from a mouse injected with PBS, Livermore, CA). Goat anti
mouse was the secondary antibody (Sigma).
Immunofluorescence Microscopy
10 µl of spore suspension was placed into each well of a multiwell slide. The slides
were pretreated with 0.01% (wt/vol) poly-L-lysine, washed twice with water and air-
dried. 10 µl of phosphate-buffered saline (PBS) was then placed into each well and
replaced with 2% (wt/vol) BSA in phosphate-buffered saline prior to the addition of
primary antibody. Monoclonal anti BclA antibody was used at a 1:5000 dilution.
Polyclonal antibodies were used at a 1:50 dilution. Polyclonal anti-BclA antibody raised
in rabbits was used at a 1:100 dilution (BEI Resources). Secondary antibody was used at
a 1:300 dilution. Alexa Fluor 488 goat anti mouse IgG or goat anti rabbit IgG were used
as the secondary antibody (Molecular probes, Life Technologies TM ).
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Spore Hydrophobicity Measurement
BATH (Bacterial Adherence to Hydrocarbons) assay was performed to measure the
hydrophobicity of spores that either have or lack BclA on their surface [16, 34]. Spore
suspensions in sterile water were prepared at OD440 0.4-0.6. The prepared samples were
mixed with various (25, 125 or 250 µl) amounts of n-hexadecane and mixed by vortexing
for 1 minute. The samples were left for 30 minutes to allow the aqueous and nonaqueous
phases to separate. The aqueous layer was carefully removed and the OD440 was
measured again. The hydrophobicity was calculated by using the equation: 100% - (OD
before / OD after) x 100%. To study whether or not heat has an impact on the
hydrophobicity of the spores, the samples were treated with heat before mixing with the
n-hexadecane. Spores adjusted to OD440 0.4-0.6 were treated with heat (37, 65 or 100 °C)
for 10 minutes and afterward left in the fridge overnight. As a control, a sample was left
at room temperature (around 25 °C) for the duration of the heat treatment. The next day,
the spore suspensions were mixed with 250 µl of n-hexadecane and the hydrophobicity as
measured.
Clumping Assay
Spores suspended in distilled water were placed on a vortex for 1 minute. OD580 was
adjusted to 0.5-0.6 for each 500 µl samples. The samples were placed in the
spectrophotometer and the OD580 was measured every 10 minutes for 90 minutes [35].
Clumping assay was performed in duplicates and the average was recorded as the
percentage of spores that did not clump at any given time.
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SyntTax
SyntTax was used to study gene preservation in bclA locus in various species.
Electron Microscopy
A pellet from 1 ml of spore stock was prepared. The pellet was mixed 1 ml of a 2.5%
glutaraldehyde, 0.1 M sodium cacodylate solution and 0.1% of ruthenium red. The
sample was incubated for 1 hour at 37 °C. Next, the sample was spun down and washed
in 1 ml of PBS. The pellet was mixed 2% osmium tetroxide, 0.1 M sodium cacodylate
solution and 0.1% ruthenium red. The pellet was incubated for 3 hours at room
temperature. Next, the pellet was washed twice with 1ml of PBS and resuspended in 100
µl of water. 300 µl of 3% melted agarose was mixed with the spore pellet and transferred
onto an agarose cushion. The sample was spun down for 30 seconds. After the sample
solidified, the pellet was cut with a razor blade into small pieces and placed into a
scintillation vial. The sample was subjected to dehydration steps in 4 ml of 30%, 50%,
70% and 100% ethanol with rocking for 1 hour in-between. Next, the samples were
mixed with 1:1 mixture of 100% ethanol and resin, followed by 100% resin. The sample
in resin was left rocking overnight at room temperature. The next day, the samples were
fished out and placed into a resin mold. Fresh resin was poured onto the sample and the
sample was left baking overnight.
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Species/Strains Genotype or description Reference or
source
B. subtilis BSn5 Wild type BGSC
B. amyloliquefaciens NRRL BD-553 Wild type USDA
B. amyloliquefaciens BGSC 10A1 Wild type BGSC
B. amyloliquefaciens NRRL BD-599 Wild type USDA
B. atrophaeus SB512 Wild type USDA
B. atrophaeus 1942 Wild type BGSC
Br. laterosporus ATCC9141 Wild type BGSC
B. methylotrophicus FZB42 Wild type BGSC
P. chitinolyticus NBRC 15660 Wild type BGSC
B. anthracis 34F2 Wild type Laboratory
collection
B. anthracis 34F2 pXO1+ pXO2- bclA::kan Laboratory
collection
B. subtilis PY79 Lab strain Laboratory
collection
E. coli RG7 GM1684 (dam-) Laboratory
collection
E. coli DH5α Cloning host Laboratory
collection
E. coli C2925H Cloning host, dam-/ dcm- NEB
E. coli SS1827 Helper strain Stibitz and
Carbonetti 1994
Table 1. Species and strains used in BclA study
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Plasmids Description Reference
pGEM-T Cloning vector Promega
pUTE29-gfp Plasmid carried green
fluorescence protein
Laboratory collection
pRP1028 Temperature sensitive vector in
Gram positive bacteria, SpecR
Plaut & Stibitz 2015
pBKJ236 Temperature sensitive vector in
Gram positive bacteria, ErmR
Plaut & Stibitz 2006
pEO-3 Shuttle vector, ErmR Mendelson &
Friedlander 2004
pIMAY Temperature sensitive vector in
Gram positive bacteria, CamR
Monk & Foster 2012
Table 2. Plasmids used in BclA study
Species Gene Sequence (5’ -3’) Prime
r
B. subtilis 03520 ttt ttt GAG CTC CTT AAC GCA TGT GGA GGT AGT AGT
AGA
FW
B. subtilis 03520 ttt ttt GAT ATC GAG ATA ATA ACG TCC TGC CAC TGG REV
B. subtilis 20885 ttt ttt GAG CTC GAT GTG ATT GTA AAT GGA GGT FW
B. subtilis 20885 ttt ttt GAT ATC TCC CCC AGC AGA CTC TAT TAA REV
B. atrophaeus 00385 ttt ttt GAG CTC TGC TGC GTA AGG GGA GTA FW
B. atrophaeus 00385 ttt ttt GAT ATC AAT GAC ATC AGC CTC TAT AGC TAC CGT REV
B. atrophaeus 01385 ttt ttt GAG CTC AAT CTC ATT GTA AAC GGA GGG FW
B. atrophaeus 01385 ttt ttt GAT ATC GAT TCC ATT CAC AAA CTC AAC REV
B. atrophaeus 04295 ttt ttt GAG CTC AAT TTA CCT AAT ATT ACA CCG GTC FW
B. atrophaeus 04295 ttt ttt GAT ATC GGT ATA ATC AGC AGA AGC GTC REV
GFP-rev ttt ttt GGT ACC TTA TTT GTA TAG TTC ATC CAT GCC REV
2GFP-FW-nostartcodon AA GAGCTC AAA GTT TAA ACT CGG AGG CGG TGG GGG
AGG GAG TAA AGG AGA AGA ACTT TTC
FW
Table 3. Oligonucleotides used in BclA study
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CHAPTER THREE
EXPERIMENTAL RESULTS
Identification of Spore-Forming Bacteria Species with bclA Homologues
Identification of Genes Homologous to bclA So far, BclA was only found on the
spore surface of B. anthracis, species closely related to it and C. difficile. It is possible the
protein is actually present in other species as well. If BclA is a protein in various
organisms, I should be able to find genes that are homologous to bclA in the genomes of
those organisms. To answer the question whether there are bclA-like genes in multiple
spore-forming bacteria, I utilized BLAST. I used a bclA sequence from B. anthracis as
my query. In a preliminary search, I did not look for similarity to the entire amino acid
sequence of BclA. As mentioned previously, the exosporium and the coat are two
different structures and their compositions are not analogous. The way BclA anchors to
the exosporium of B. anthracis is most likely not conserved across species with or
without exosporia. I expect that the NTD will differ among these two classes of species
(and perhaps within classes as well) and it will contain a sequence that targets this protein
to the coat or the exosporium. For this reason I decided to split my search for BclA
orthologues into two parts. First, I looked for proteins that have similar NTD. Second, I
looked for collagen-like proteins with CTD similar to BclA. Once I established
which organisms have sequences homologous to BclA, I focused on spore-forming
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bacteria from Bacilli. Multiple species from Bacillaceae and Paenibacillaceae showed
bclA homology. Within those species, I found multiple sequences homologous to bclA.
After I created a list of bclA-like amino acid sequences, I looked for significant similarity
between entire sequences of B. anthracis bclA and bclA-like genes, similarities in NTD
only and CTD only. There are three domains in the BclA protein: the N-terminal domain,
collagen-like region and C-terminal domain. In my analysis, I want to look for the
sequence similarity in those domains between B. anthracis bclA and bclA-like sequences
in diverse genomes. Identifying similarities in N-terminal domain sequences could help
recognize a conserved region responsible for BclA anchoring to the surface of a spore.
Comparing the collagen-like region will help me determine if the GXX triples are the
same across the species or if there is a variation in the composition. I will be able to
establish, in particular, if the (GPT)5GDTGTT region is found across the species or if it is
B. anthracis-specific. Lastly, the C-terminal domain is especially immunogenic. I will be
able to see whether this domain is preserved and to what extent.
The BLAST analysis revealed many more species with bclA-like genes than
previously noted. Identity to the sequence was not only found in genomes of all members
of B. cereus group (as already noted), but also in many other species belonging to the
Bacillaceae family (Table 4). In addition, members of the families Paenibacillaceae,
Streptococcaceae and Clostridiaceae also showed some identity with B. anthracis bclA.
The Streptococcaceae is not known to harbor spore-forming species. The majority of
species with bclA homologues came from spore-forming bacteria.  The highest sequence
similarity was found in the collagen-like region. Collagen-like regions were not identical
to the one found in B. anthracis. The signature region (GPT)5GDTGTT was only found
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in B. anthracis. The CLR in most of the species had GXT repeats. The C-terminal
domain is not conserved across the species. Species belonging to the B. cereus group had
high similarity in C-terminal domains. The remaining species had either some similarity
to CTD or none. N-terminal domain sequence is only conserved among B. cereus group
species (Table 5). This was expected as this protein region anchors BclA to the basal
layer, which is likely to be similar among member of B. cereus group. Although Table 4
and Table 5 list only the results on the species level, for many of the organisms, I was
able to identify multiple strains with bclA homologues. I narrowed down my research to
the Bacillus, Paenibacillus, Brevibacillus and Lysinibacillus genera and analyzed the
genomes of multiple strains that showed identity to bclA (Table 6). I found that many of
the strains have multiple collagen-like proteins. As previously mentioned, the similarity
was mostly coming from the CLR. There were a few collagen-like proteins that had high
E values when compared to BclA from B. anthracis. That might suggest that, those
proteins are not BclA homologues. I was not able to show that any of the N-termini
present in bclA-like sequences was significantly similar to N-terminus of BclA in B.
anthracis. There was no N-terminus similar in length to the N-terminus in BclA of B.
anthracis. Moreover, the length of the N-termini varied greatly among the sequences
ranging from 2 to 240 amino acids. In some cases, it was difficult to establish how big the
N-terminus is. In those cases, there would be a few GXT triples present followed by non-
collagen region, which in turn, was followed by GXT triplets. Only 10 out of 94
sequences have significant similarity in C-terminal domain. This could suggest that C-
termini are divergent across the species.
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Species
Query
covered (%) E value
Identity
(%) Similarity to CTD
Bacillus anthracis 100 0 100 yes
Bacillus thuringiensis 100 4e -147 82 yes
Bacillus cytotoxicus 89 3e -110 79 yes
Bacillus cereus 97 9e -109 77 yes
Streptococcus pneumoniae 97 9e -92 91 yes
Bacillus weihenstephanensis 96 1e -86 74 yes
Bacillus mycoides 95 1e -86 84 yes
Syntrophobotulus glycolicus 99 7e -75 60 yes
Clostridium aerotolerant 99 3e -67 56 yes
Clostridium sordellii 99 4e -63 54 yes
Clostridium aceticum 99 4e -62 47 yes
Brevibacillus laterosporus 100 2e -61 48 yes
Clostridum diolis 99 7e -61 55 yes
Clostridium celerecresens 100 3e -60 54 yes
Bacillus pumilus 100 3e -60 51 yes
Bacillus bombysepticus 96 2e -58 55 yes
Clostridium argentinensis 99 1e -57 47 yes
Clostridium difficle 77 2e -57 60 yes
Paenibacillus chitinolyticus 99 3e -57 50 yes
Kangiella koreensis 60 4e -57 65 no
Clostridium beijerinckii 61 7e -57 76 no
Bacillus endophyticus 60 5e -56 75 yes
Clostridium sacchardyticum 99 9e -56 50 yes
Peptoclostridium difficle 77 1e -55 62 yes
Clostridium autoethanogenum 88 1e -55 77 yes
Clostridium methoxybenzovorans 99 2e -55 51 yes
Blautia producta 97 3e -55 53 yes
Bacillus invictae 97 5e -55 77 yes
Clostridium ljungdahlii 90 5e -55 77 yes
Bacillus altitudinis 100 6e -55 49 yes
Haemophilus parasuis 90 1e -54 52 yes
Bacillus licheniformis 98 1e -53 79 yes
Bacillus safensis 100 9e -53 51 yes
Kangiella aquimarine 70 1e -52 62 no
Bacillus amyloliquefaciens 61 1e -52 73 no
Parachlamydiaceae bacterium 90 3e -52 55 yes
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Paenibacillus pinihumi 61 3e -52 55 yes
Waddlia chondrophila 94 7e -52 49 yes
Acinetobacter quillouiae 61 9e -52 67 no
Erysipelatoclostridium ramosum 100 1e -51 72 yes
Bacillus aerophlius 64 1e -51 67 no
Alkaliphilus metalliredigens 93 2e -51 47 yes
Bacillus subtilis 94 2e -51 53 yes
Desulfotomatulum quttoideum 94 7e -51 79 yes
Desulfitobacterium hafniense 59 9e -51 65 no
Escherichia coli 62 1e -49 56 no
Fictibacillus gelatini 99 2e -49 73 yes
Hungatella hathewayi 98 5e -49 49 yes
Bacillus licheniformis 62 1e -48 71 yes
Bacillus methylotrophicus 61 2e -48 73 no
Bacillus atrophaeus 61 3e -48 70 no
Paenibacillus mucilaginosus 62 4e -48 69 no
Gottschalkia acidurici 100 7e -48 43 yes
Lysinibacillus varians 96 2e -47 46 yes
Mesorhizobium loti 60 3e -47 68 no
Clostridium tyrobutyricum 99 4e -46 58 yes
Parachlamydia acanthamoebae 60 7e -46 57 no
Bacillus gaemokensis 60 9e -46 78 no
Bacillus amyloliquefaciens subsp. Plantarum 62 2e -45 65 yes
Bacillus mojavensis 99 4e -45 67 yes
Pandoravirus salinus 62 4e -45 48 no
Streptococcus pyogenes 60 5e -45 50 no
Clostridium scatologenes 64 6e -45 62 no
Paenibacillus borealis 57 4e -44 68 no
Brevibacacillus brevis 62 2e -43 61 no
Clostridium indolis 96 5e -43 73 yes
Paenibacillus polymyxa 60 2e -42 70 no
Streptococcus equi 61 2e -42 50 no
Streptosporangium roseum 80 3e -42 58 yes
Robinsoniella peoriensis 61 1e -41 59 no
Aneurinibacillus migulanus 62 2e -41 63 no
Clostridium baratii 92 3e -41 47 yes
Paenibacillus assamensis 60 6e -41 71 no
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Mycobacterium phage Tiffany 71 1e -40 47 yes
Cellulophaga baltica 62 3e -40 50 yes
Muricauda ruestringensis 75 5e -40 45 yes
Pandoravirus inopitanum 61 5e -40 46 no
Paenibacillus massiliensis 93 9e -39 56 yes
Kangiella geojedonensis 62 1e -38 48 no
Pithovirus sibericum 59 2e -38 64 no
Alkaliphilus oremlandii 49 2e -38 70 no
Dyadobacter crusticola 61 7e -35 47 no
Methylobacterium aquaticum 61 1e -34 51 no
Bacillus marisflavis 62 1e -34 51 no
Streptacidiphilus albus 61 2e -34 56 no
Burkholderia phymatum 60 4e -34 54 no
Anaerotruncus colihominis 60 1e -33 44 no
Legionella pneumophila 69 1e -33 44 no
Bacillus clausii 62 2e -29 67 no
Paenibacillus alvei 60 8e -18 62 no
Table 4.Results of BLAST search where CLR and CTD of BclA were used together as
the query.
Species Query covered (%) E value Identity (%)
Bacillus anthracis 100% 8e -19 100%
Bacillus cereus 100% 3e -18 100%
Bacillus thuringiensis 100% 4e -18 100%
Bacillus
weihenstephanensis 100% 2e -17 100%
Bacillus mycoides 95% 1e -14 95%
Bacillus cytotoxicus 97% 2e -06 67%
Table 5.Results of BLAST search where NTD of BclA was used as the query
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Query: BclA from B.
anthracis Query: C-terminus of BclA
from B. anthracis
Query: N-terminus of BclA
from B. anthracisAccession number:
CAD56869.1
species/
strain name
Lengt
h of
BclA-
like
protei
n
Accession
number
Query
covere
d**
E
value
Identity
***
Query
cover
**
E
value
Identity
***
Query
covere
d**
E
val
ue
Identity
***
length of
N-
terminus
Bacillus
licheniformis
ATCC 14580
955 WP_011197647 48%
2.00E-
27 53% 96%
1.00E
-13 45% NSS* 162aa
1259 WP_011197646 88%
2.00E-
54 65% 3% 3.9 60% NSS* 163aa
Bacillus
licheniformis
5-2-D
420 WP_01688
6284
46% 6.00E-07 80% 9% 4.6 42% NSS* 160aa
1054 WP_016886285 90%
8.00E-
63 78% 19% 2.7 80% NSS* 156aa
Bacillus
licheniformis
9945A
534 WP_020450548 68%
4.00E-
38 80% 21% 0.35 38% NSS* 160aa
1874 WP_051143316 85%
9.00E-
62 79% 3% 4.4 60% NSS* 154aa
Bacillus
amyloliquefaci
ens DSM 7
2083 CBI41846 91% 3.00E-53 65% 35% 0.088 27% 47% 0.2 42% 152aa
621 CBI41847 71% 6.00E-26 52% 31% 1.9 31% 57%
0.0
92 26% 70aa
622 CBI42530 46% 6.00E-20 74% 25% 0.043 32% 50%
0.6
1 40% 101aa
Bacillus
amyloliquefaci
ens LL3
2200 AEB62317 91% 2.00E-52 65% 47% 0.21 42% 47%
0.2
1 42% 152aa
586 AEB62960 51% 2.00E-07 73% 36% 0.045 32% 50%
0.5
4 40% 101aa
Bacillus
amyloliquefaci
ens KHG19
662 WP_042634957 82%
1.00E-
54 48% 12% 1.6 25% NSS* 158 aa
353 WP_052484216 9% 0.22 36% 40% 0.042 36% NSS* 160aa
948 WP_042634958 65%
9.00E-
50 54% 31% 7.3 26% NSS* 72aa
371 WP_052484221 26%
2.00E-
08 36% 12% 1.2 60% NSS* 2aa
365 WP_052484219 54%
4.00E-
08 44% 28% 0.024 35% 70%
0.2
4 40% 101 aa
Bacillus
atropheus
1942
1335 ADP31235 63% 6.00E-53 69% NSS 10% 4 100% 158aa
511 ADP31037 NSS* 30% 0.42 47% NSS* 25aa
513 ADP31813 46% 6.00E-08 51% 10% 4.6 43% 75%
0.1
6 58% 101aa
Bacillus
atrophaeus
NRS 1221a
513 AJF84609 46% 6.00E-08 51% 10% 4.6 43% 75%
0.1
6 58% 101aa
266 AJF83915 NSS* 5% 3.4 57% NSS* 11aa
1692 AJF84093 65% 3.00E-55 69% NSS* 10% 4.8 100% 158aa
Bacillus
subtilis strain
T30
488 WP_045590038 18%
3.00E-
09 62% 5% 3.4 57% NSS* 42aa
1086 WP_052673360 76%
3.00E-
46 52% NSS NSS* 154aa
Bacillus
subtilis BSn5
650 ADV92637 91% 3.00E-60 54% 39% 0.017 28% NSS* 7aa
240 ADV93334 41% 3.00E-09 72% 18% 0.41 38% NSS* 13aa
238 ADV96781 57% 2.00E-04 70% NO C-TERMINUS 50% 1.1 35% 154aa
Bacillus
subtilis strain
Bs-916
428 WP_038462142 62%
4.00E-
07 73% 40% 0.042 36% NSS* 160aa
581 WP_03846
2140
82% 4.00E-58 51% 12% 1.6 25% NSS* 158aa
23
407 WP_007407226 25%
5.00E-
06 35% 8% 0.83 35% 70%
0.2
6 40% 101aa
533 WP_038462387 90%
7.00E-
11 43% 12% 1.2 60% NSS* 20aa
Bacillus
subtilis SG6 1541
WP_03842
9006 62%
2.00E-
54 67% 39% 0.014 28% NSS* 154aa
Bacillus
subtilis ATCC
13952
2155 AIW35839 91% 5.00E-49 68% NSS 47% 0.2 42% 152aa
627 AIW32755 52% 9.00E-23 59% 31% 1.7 31% 57%
0.0
88 26% 72aa
622 AIW33350 46% 6.00E-20 74% NSS* 50%
0.6
1 40% 101aa
Bacillus
methylotrophic
us str. FZB42
459 WP_012117058 64%
1.00E-
37 49% 40% 4.4 29% NSS* 72aa
665 WP_012117056 82%
2.00E-
42 51% 12% 1.7 25% NSS* 158aa
365 WP_012117390 56%
1.00E-
12 45% 9% 1.1 38% 70%
0.2
8 40% 101aa
416 WP_012117057 9% 5.1 57% NSS* NSS* 160aa
Bacillus
methylotrophic
us NAU-B3
633 WP_022553453 61%
6.00E-
14 75% 28% 0.027 35% 50%
0.5
9 40% 101aa
687 WP_022552743 70%
9.00E-
55 59% 40% 4.4 29% NSS* 72aa
Bacillus
methylotrophic
us JS25R
687 WP_022552743 70%
9.00E-
55 59% 40% 4.4 29% NSS* 72aa
709 WP_052110583 64%
7.00E-
57 72% 28% 0.024 35% 42% 1.6 41%
21aa or
244
Bacillus
pumilus ATCC
7061
342 WP_034620927 68%
2.00E-
51 69% N/A N/A N/A
903 WP_003213888 57%
1.00E-
56 69% 14% 2.8 37% 30%
0.5
3 58% 176aa
917 WP_003211344 92%
1.00E-
58 55% 86% 0.045 32% 32%
0.5
2 54% 50 aa
Bacillus
pumilus
SAFR-032
1865 ABV62475 82% 4.00E-50 65% 45%
6.00E-
04 34% 52% 0.2 43% 140 aa
345 ABV62341 5% 1 42% 37% 0.091 32% NSS* 9aa
Bacillus
pumilus strain
LK21
420 KML12809 89% 9.00E-68 50% 59%
3.00E-
05 35% N/A N/A
468 KML10775 56% 4.00E-54 66% N/A 65%
0.0
14 43% 205AA
179 KML10797 92% 6.00E-14 64% 40% 0.001 37% NSS* 2aa
Bacillus
safensis
RIT372
348 KIZ49468 57% 3.00E-43 72% N/A N/A N/A
489 KIZ54948 90% 3.00E-59 50% 59%
2.00E-
05 35% NSS* N/A
Bacillus
safensis strain
JPL_MERTA8
1876 WP_046311377 97%
4.00E-
56 52% 45% 0.001 34% 52%
0.2
6 43% 204aa
Bacillus
invictae DSM
26896
292 KJF45741 70% 3.00E-53 65% N/A N/A N/A
304 KJF46841 73% 3.00E-18 74% N/A 80%
0.0
05 43% 205aa
378 KJF45766 87% 1.00E-62 52% 59%
2.00E-
05 35% N/A N/A
740 KJF47812 59% 4.00E-62 67% 14% 3.3 42% NSS* 5aa
192 KJF46970 73% 8.00E-07 60% 28%
4.00E-
04 39% N/A N/A
Bacillus
altitudinis
RIT380
199 KLV13925 69% 3.00E-54 76% N/A N/A N/A
491 KLV21725 92% 2.00E-62 49% 30%
2.00E-
05 41% N/A N/A
224 KLV13929 71% 5.00E-56 73% N/A N/A N/A
492 KLV13937 82% 1.00E-55 67% N/A N/A N/A
Bacillus
xiamenensis
strain HYC-10
171 EKF33836 52% 2.00E-09 58% 24% 0.65 33% N/A 3 aa
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Bacillus
endophyticus
2102
267 WP_019395434 88%
2.00E-
32 50% 91%
2.00E-
07 29% NSS* 15aa
194 WP_019393702 69%
1.00E-
17 46% 15% 0.43 52% 12%
0.5
3 80% N/A
Paenibacillus
daejeonensis
DSM 15419
1659 WP_020619414 69%
4.00E-
23 57% 10% 0.14 36% NSS* 101aa
696 WP_020620726 71%
2.00E-
44 57% 65%
5.00E-
04 34% NSS* 101aa
700 WP_020620725 70%
1.00E-
40 54% 56% 0.48 28% NSS* 101aa
693 WP_020620723 70%
4.00E-
43 44% NSS* NSS*
101 or
221 aa
693 WP_020620724 85%
4.00E-
38 40% 76% 0.007 32% 57% 2.2 57%
101 or
225 aa
700 WP_020620722 64%
1.00E-
36 42% 53%
3.00E-
04 33% NSS*
101 or
221aa
693 WP_020620727 96%
4.00E-
40 40% 37% 0.007 27% NSS*
101 or
222aa
553 WP_020620713 56%
4.00E-
31 50% 29% 0.006 38% NSS* 240
Paenibacillus
borealis DSM
13188
501 WP_052429824 20% 0.002 68% 15% 3.9 45% NSS* 5aa
514 WP_052429797 58%
1.00E-
52 68% 25% 1.8 35% NSS* 24aa
774 WP_052429702 61%
6.00E-
31 57% 59% 0.097 30% NSS* 341aa
Paenibacillus
chitinolyticus
NBRC 15660
DNA
210 WP_053228787.1 83%
1.00E-
33 45% 93%
5.00E-
17 39% NSS* 2aa
Paenibacillus
assamensis
DSM 18201
338 WP_028595677 77%
2.00E-
05 40% 62%
4.00E-
08 33% 25% 3.3 50% 101aa
395 WP_051217543 75%
1.00E-
40 66% 42% 0.34 28% NSS* 88aa
770 WP_036605366 95%
4.00E-
49 71% 22% 0.55 32% NSS* 101aa
410 WP_028595663 88%
2.00E-
34 46% 31%
8.00E-
06 54% 20%
0.1
3 63% 104aa
405 WP_051217544 44%
6.00E-
17 66% 43% 0.93 34% NSS* 95aa
Paenibacillus
polymyxa
WLY78
376 WP_029518313 84%
1.00E-
46 67% N/A 32% 1.5 56% 162 aa
Brevibacillus
laterosporus
LMG 15441
372 AIG25670 82% 7.00E-26 78% 26% 0.12 53% NSS* 165aa
620 AIG26331 92% 2.00E-69 49% 62%
6.00E-
06 28% NSS* 158aa
467 AIG24974 11% 3.00E-04 43% 31%
5.00E-
06 44% NSS* 54aa
Brevibacillus
brevis NBRC
100599 DNA
312 WP_041749728 41% 0.22 69% 33% 0.045 25% 55%
0.9
2 36% 102aa
1003 WP_012684061 59%
1.00E-
51 61% 12% 0.38 53% NSS* 31aa
Brevibacillus
reuszeri 1876 KNB69934 84%
2.00E-
29 50% 26% 0.029 37% NSS* 100aa
Lysinibacillus
varians GY32 407
WP_03851
0599 88%
3.00E-
55 46% 43% 2 27% N/A 1aa
Lysinibacillus
fusiformis RB-
21
763 WP_053833723 62%
2.00E-
46 55% 15% 3.2 40% NSS* 45aa
Lysinibacillus
boronitolerans
JCM 21713
521 WP_052125391 68%
3.00E-
43 46% 15% 3.1 40% 95% 2.1 56% 44aa
Lysinibacillus
sphaericus
1987
422 WP_051998216 54%
2.00E-
33 56% 15% 2.8 40% N/A N/A
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Table 6. Results of BLAST search where 382 amino acid sequence of BclA was used as
the query. NSS*- no significant similarity. **Query covered- percent of the BclA
sequence that overlaps the subject sequence. *** Identity- percent similarity between the
BclA sequence and subject sequences over the length of overlapped region. N/A – not
applicable meaning no NTD present. Light gray color-species whose bclA loci were
established by SyntTax
Analysis of bclA Loci in Chosen Species The bclA locus is conserved in the genomes
of B. cereus group members. The order in which glycosyltransferases and
methyltransferases surround bclA is preserved (Figure 2). I asked if the bclA locus is
conserved in other spore-forming species. Specifically, I wanted to know if the bclA
locus was universal to all species or if it was distinct and only preserved in closely related
species (like B. subtilis group). I also wanted to know if glycosyltransferases and
methyltransferases genes surrounded bclA. To look for conservation in the bclA locus
across species and presence of glycosyltransferases and methyltransferases, I used
SyntTax. SyntTax is a web service that enables studying the conservation of gene order
in chosen organisms. Because SyntTax only operates on fully sequenced genomes, I was
not able to investigate bclA loci in all of the species listed in Table 6. Therefore, I focused
my analysis on a group of species: B. subtilis BSn5, B. atrophaeus 1942, B. atrophaeus
NRS 1221a, B. methylotrophicus FZB42, B. licheniformis ATCC 14580 and B. pumilus
SAFR-032.
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Figure 2: A cartoon depicting bclA locus in B. cereus group species.
B. subtilis BSn5 genome possesses three bclA-like genes in two loci (Figure 3 and
Figure 4). Two interesting observations can be made about these loci. First, both of the
loci are surrounded by phage-like genes suggesting an integration event. Second, these
loci are absent from common lab strains like B. subtilis PY79 or B. subtilis 168 (Figure 5
and Figure 6). Additionally, locus 1, which has two bclA-like genes, is also present in B.
subtilis subsp. subtilis str. OH_131_1, B. subtilis strain RO_NN_1 and B. subtilis
spizizenii strain W23 (Figure 7). My analysis shows the gene order in bclA locus of B.
subtilis subsp. subtilis str. OH_131_1 is almost identical to that of B. subtilis BSn5. There
are two bclA-like genes in both strains surrounded by glycosyltransferases and
methyltransferases. Moreover, both loci contain phage-like genes downstream of bclA
genes. However, phage-like gene upstream of bclA is only conserved in B. subtilis Bsn5
whereas B. subtilis subsp. subtilis str. OH_131_1 has a noncoding region. Interestingly,
bclA is missing in B. subtilis RO_NN_1. Only methyltransferases and
glycosyltransferases are present. It is difficult to conclude whether this locus is related to
BSn5 bclA locus as there are only four genes that seem to be preserved. B. subtilis
spizizenii strain W23 has one bclA-like gene surrounded by methyltransferases and
glycosyltransferases as well. Locus 2 bearing bclA in B. subtilis BSn5 is not present in
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any other B. subtilis strain (Figure 8). Intriguingly, a similar locus was found in B.
pumilus SAFR-032. It is important to note, however, that only four genes seem to be
conserved. No methyltransferases or glycosyltransferases are present in either B. subtilis
BSn5 or B. pumilus SAFR-032 loci. The second bclA locus in B. pumilus SAFR-032 is
only found in B. pumilus strains (Figure 9). No glycosyltransferases or methyltransferases
are found in this locus. B. atrophaeus 1942 has three bclA genes found in three different
loci. Locus 1 is present in B. atrophaeus NRS_1221A (AJF84093) and another B.
atrophaeus strain (Figure 10). This locus is also present in B. methylotrophicus
(WP_012117056, WP_012117057 and WP_012117058), B. subtilis, and B.
amyloliquefaciens. There are no methyltransferases or glycosyltransferases present.
Locus 2 is preserved in B. atrophaeus and B. subtilis strains (Figure 11). There is one
glycosyltransferase upstream of bclA gene. Locus 3 is present in B. atrophaeus strains, B.
methylotrophicus, B. amyloliquefaciens and B. subtilis (Figure 12). There is a
methyltransferases and a glycosyltransferase present. Both bclA genes identified in B.
licheniformis 14580 are present in the same locus (Figure 13). This locus is conserved
only in B. licheniformis strains. There are no methyltransferases or glycosyltransferases
present.
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Figure 3. A cartoon depicting the first bclA locus in B. subtilis BSn5.This locus contains
two bclA-like genes.
Figure 4. A cartoon depicting the second bclA locus in B. subtilis BSn5.This locus
contains one bclA-like gene.
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Figure 5. A cartoon comparing the first bclA locus found in B. subtilis BSn5 to the lab
strains.
Figure 6. A cartoon comparing the second bclA locus found in B. subtilis BSn5 to the lab
strains.
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Figure 7: A cartoon depicting similarity between one of two bclA loci in B. subtilis BSn5
and other B. subtilis strains.
Figure 8: A cartoon depicting similarity between one of two bclA loci in B. subtilis BSn5
and B. pumilus SAFR-032.
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Figure 9: A cartoon depicting one of two bclA loci in B. pumilus SAFR-032.
Figure 10: A cartoon depicting similarity between one of three bclA loci in B. atrophaeus
1942 and other B. atrophaeus strains.
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Figure 11: A cartoon depicting similarity between one of three bclA loci in B. atrophaeus
1942 and other B. atrophaeus strains.
Figure 12: A cartoon depicting similarity between one of three bclA loci in B. atrophaeus
1942 and other B. atrophaeus strains.
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Figure 13: A cartoon depicting similarity between bclA loci in B. licheniformis 14580 and
other B. licheniformis strains.
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Conclusion Based on my limited analysis I can conclude bclA loci vary across
species. The bclA locus found in B. anthracis is only conserved in B. cereus group. The
locus contains one bclA gene surrounded by multiple methyltransferases and
glycosyltransferases. This is different from bclA loci found in other species (B. subtilis
BSn5, B. methylotrophicus FZB42 or B. licheniformis ATCC 14580) where two or three
bclA genes are present close to each other. Glycosyltransferases and methyltransferases
were not present in the proximity of all bclA-like genes. In fact, only few B. subtilis
strains had multiple glycosyltransferases and methyltransferases in their bclA loci. Most
of the bclA loci lack the transferases or have just one or two. In the future, it would be
important to extend the bclA locus analysis to other species. For now, we only know the
composition of the bclA loci in species closely related to B. anthracis and B. subtilis.  It
would be interesting to know, what type of genes surround bclA in genomes of species
that represent Paenibacillaceae and Clostridiaceae. Are glycosyltransferases and
methyltransferases close to bclA in the genomes of those species or is this feature only
preserved in B. cereus group? A greater analysis of bclA loci would allow us to tell if
there is any common feature to all of them.
Presence of BclA in Species that have bclA Homologous
Introduction Based on my genomic analysis, I know that bclA genes are present in
the genomes of many spore-forming bacteria. This finding is not sufficient to conclude
BclA is a spore protein in species harboring bclA gene as it is not known if the genes are
being transcribed and translated during the sporulation. In order to explore whether BclA
is present in spores that harbor bclA, I performed Western Blot and IFM. Additionally, I
prepared thin-section TEM of unpurified spores.
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Bacillus subtilis I identified three bclA-like genes in the genome of B. subtilis BSn5
(Table 6). This finding was surprising as the spores of B. subtilis do not possess an
exosporium. To learn whether spores of B. subtilis BSn5 have hair-like projections on the
surface I performed EM. I was able to visualize the crust of the spores. I was not able to
detect hair-like projections on the spores (Figure 14). This finding could mean that either
BclA does not produce hair-like structures on the spore surface of B. subtilis BSn5 or we
cannot detect them when we stain with the ruthenium red. I questioned whether BclA is a
spore protein in this species. First, I investigated whether I can detect BclA by Western
blot. This experiment allowed determining if BclA is present in the coat of the B. subtilis
BSn5 spore. I chemically extracted coat proteins by SDS and DTT (denaturing agents)
and heat treatment. The chemical extraction was followed by SDS-PAGE and
immunodetection. Two antibodies are used in this study to detect the presence of BclA:
anti-BclA monoclonal antibody and anti-BclA antiserum (polyclonal antibody). The
monoclonal antibody is specific for the C-terminus of B. anthracis BclA. Anti-BclA
antiserum was raised against the entire B. anthracis BclA and we do not know what
region of BclA it detects. The negative control for this study is the serum from a mouse
injected with PBS or pre-immune mouse serum. The monoclonal antibody detected a
high molecular species (>170kDa) in B. subtilis BSn5 (Figure 15 lane 3). Additionally,
anti-BclA antiserum also detected a high molecular species (Figure 15 lane 5). This
protein was not detected by the negative control (Figure 15 lane 4). Western blot results
suggest that BclA is a spore protein in B. subtilis BSn5. Interestingly, according to the
bioinformatics analysis, BclA is expected to be either 26 kDa or 71 kDa. The fact that it
is detected as a high molecular weight species suggests BclA in B. subtilis BSn5 is
36
glycosylated as BclA in B. anthracis is. Alternatively, it might mean BclA in B. subtilis
BSn5 is present in complexes that do not disassociate upon DTT and SDS treatment.
Knowing that BclA is a spore protein in B. subtilis BSn5, I asked whether I can detect
the protein on the spore surface. To answer this question, I used IFM. 10 µl of spore
suspension was transferred to a multiwall glass slide. Spores were first incubated with
primary antibodies and afterwards with fluorescently labeled secondary antibodies. Only
a subset of spores was fluorescently labeled when anti-BclA antiserum was applied
(Figure 16, d-f). No fluorescence was observed with the PBS induced serum (Figure 16,
a-c). This suggests the signal I detected on a subset of spores was indeed BclA. No
fluorescence was detected when the monoclonal antibody was applied to the spores
(Figure 16, g-i). This finding suggests the C-terminus of BclA is not accessible to the
antibody on the spore surface of B. subtilis BSn5. The finding that only a subset of spores
had BclA on the spore surface could explain why we did not see hair-like structures on
the spores. Possibly, in our EM analysis, we did not look at enough spores to find hair-
like projections.
Bacillus amyloliquefaciens B. amyloliquefaciens is another example of bacterium
whose spores do not produce exosporia. BLAST analysis showed there are at least three
strains of B. amyloliquefaciens that have bclA-like genes in their genomes (Table 6). The
Driks lab has a collection of 6 different strains of B. amyloliquefaciens. However, their
sequences are not present in NCBI, preventing me from determining whether they encode
BclA-like proteins. Nevertheless, investigating our strains could tell me something about
the frequency of BclA in nature. First, I questioned if I can visualize hair-like projections
of the spore surface of one of the strains, B. amyloliquefaciens NRRL BD-553. I was not
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able to see any hair-like structures on the spore surface (Figure 17). This could mean
either BclA is not present in that strain or alternatively it does not form hair-like
structures on the spore surface. Next, I wanted to know if I can detect BclA by
immunological methods. I investigated three strains: B. amyloliquefaciens NRRL BD-
553, B. amyloliquefaciens BGSC 10A1 and B. amyloliquefaciens NRRL BD-599. I used
Western blot to answer the question whether BclA is a spore coat protein. The
monoclonal antibody detected proteins only in B. amyloliquefaciens NRRL BD-553
(Figure 18, lane 1). Interestingly, multiple bands (>70 kDa, >40 kDa and <40 kDa) were
detected. Sylvestre et al. observed a similar pattern, in which anti-BclA monoclonal
antibody detected multiple bands in two B. anthracis strains [11]. She suggested that this
multiple band pattern was due to post-translational modification and/or stability of the
glycosylation of BclA. The monoclonal antibody did not bind to any proteins extracted
from B. amyloliquefaciens BGSC 10A1 or B. amyloliquefaciens NRRL BD 599 (Figure
18, lane 2 and lane 3). This result suggests BclA is not a spore protein in those two
strains. Alternatively, it could mean that BclA is present but its C-terminal domain is
different than in B. anthracis. The anti-BclA antiserum detects multiple bands (> 40 kDa,
< 40 kDa, around 31 kDa, and around 20 kDa) in B. amyloliquefaciens NRRL BD-553
(Figure 18, lane 4). The same sized bands are detected in the negative control (Figure 18,
lane 7). This suggests the anti-BclA antiserum does not detect BclA in the coat protein
extraction. The anti-BclA antiserum does not detect any proteins in B. amyloliquefaciens
BGSC 10A1 (Figure 18, lane 5). In the spore protein extract from B. amyloliquefaciens
NRRL BD 599, the same proteins are detected both by the polyclonal antibody as well as
the negative control (Figure 18, lanes 6 and 9). Overall, the results suggest BclA (with
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preserved C-terminus) is only present in B. amyloliquefaciens NRRL BD-553. Based on
the monoclonal and the polyclonal antibody results, either BclA in not present in the coat
of B. amyloliquefaciens BGSC 10A1 spores or BclA is not detected with our antibodies.
BclA is not detected in B. amyloliquefaciens NRRL BD 599 with our antibodies.
I performed IFM to answer the question whether BclA is a surface protein on the B.
amyloliquefaciens spores. IFM was performed on two strains: B. amyloliquefaciens
NRRL BD-553 and B. amyloliquefaciens BGSC 10A1. Based on the Western blot results,
I predicted BclA will only be found in B. amyloliquefaciens NRRL BD-553. Both the
polyclonal antibody (Figure 19, a-c) and the monoclonal antibody (Figure 19, g-i)
recognized proteins on the spore surface of B. amyloliquefaciens NRRL BD-553.
Interestingly, the signal from the monoclonal antibody was only detected at the pole of
spores. This result might indicate the C-terminal domain of BclA is only accessible to the
antibody at the pole. Neither polyclonal antibody (Figure 19, d-f) nor monoclonal
antibody (Figure 19, j-l) recognized any proteins on the surface of B. amyloliquefaciens
BGSC 10A1 spores. No proteins were detected on the surface of spores in either strain by
the negative control (Figure 19, m-o and p-r). Based on these results, only B.
amyloliquefaciens NRRL BD-553 has BclA on the spore surface. Interestingly, it seems
BclA does not form hair-like structures on the spore surface. Alternatively, the hair-like
projections are present but I cannot detect with our method.
Bacillus atrophaeus B. atrophaeus is another example of species that produces spores
without exosporia. I chose two strains of B. atrophaeus: SB512 and 1942. B. atrophaeus
SB512 is a strain from the Driks lab collection that has not been sequenced. B.
atrophaeus 1942 has been sequenced. Based on the bioinformatics analysis (Table 6),
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there are three genes encoding collagen-like proteins in B. atrophaeus 1942 and two of
them are homologous to bclA. The predicted molecular weight of the proteins is 56 kDa,
56 kDa and 147 kDa. First, I asked if I can visualize hair-like projections of the spore
surface of B. atrophaeus 1942. I was not able to see any hair-like structures on the spore
surface (Figure 20). I used Western blot to investigate if BclA is a spore protein in B.
atrophaeus SB512 and 1942. Western blot analysis showed there is a high molecular
species present in B. atrophaeus SB512 (Figure 21 lane 1). The high molecular species
detected by monoclonal antibody was not detected by anti-BclA antiserum in Western
blot (Figure 21, lane 2). This could indicate BclA protein is different from B. anthracis
BclA in a way that makes it undetectable by the anti-BclA antiserum. Another possibility
is that there is a different protein than BclA on the spore surface that is recognized by the
monoclonal antibody. High molecular species were also detected by the monoclonal
antibody in B. atrophaeus 1942 (Figure 22, lane 1). There were multiple proteins detected
ranging from 55 to 100 kDa. The 55 kDa band could indicate a monomer form of one of
the BclA proteins in B. atrophaeus 1942. This could mean that this protein is not
glycosylated. Higher molecular weight species could indicate that the protein is
glycosylated or in a complex with other proteins. This complex would have to be stable
even after SDS-DTT and heat treatment. Species detected by anti-BclA antiserum were
also detected by the negative control (Figure 22, lane 2 and 3). To determine if BclA is a
spore surface protein in B. atrophaeus, I used IFM. Monoclonal antibody detects proteins
at the poles of B. atrophaeus SB512 spores (Figure 23, a-c). Based on this result we can
infer either BclA is present only at the poles of spores or BclA is present on the entire
surface but the C-terminal domain is accessible to the antibody only at the poles. Neither
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anti-BclA antiserum nor the negative control detected any proteins on the surface of the
spores (Figure 23, g-1 and d-f, respectively). A similar pattern of BclA localization was
observed in B. atrophaeus 1942. The monoclonal antibody detected BclA at the poles of
the spores (Figure 24, a-c). Neither anti-BclA antiserum nor the negative control detects
any proteins on the surface of the spores (Figure 24, d-f and g-i).
Bacillus methylotrophicus B. methylotrophicus FZB42 has four bclA-like genes in its
genome (Table 6). I performed Western blot to investigate whether BclA is a coat protein
in B. methylotrophicus FZB42. The monoclonal antibody detected multiple high
molecular weight species (Figure 25). This finding suggests BclA is a coat protein in B.
methylotrophicus FZB42. I speculate either BclA is present in protein complexes that
resist the denaturating treatment or the protein is subject to degradation and hence the
multiple bands. Alternatively, BclA could be glycosylated differently. My third
speculation is the monoclonal antibody detects BclA products from multiple bclA-like
genes. IFM was done with the monoclonal antibody to see whether BclA is surface
exposed in B. methylotrophicus FZB42. Fluorescence was only present at the poles of the
spores (Figure 26). These data lead to the conclusion BclA is localized at the poles of the
B. methylotrophicus FZB42 spores. An alternative view is BclA is only accessible to the
antibody at the poles of the spores.
Paenibacillus chitinolyticus and Brevibacillus laterosporus are exosporium-positive
species that belong to Paenibacillaceae family. If I find BclA on the surface of spores of
these two species I will conclude B. cereus group members are not the only ones that
produce spores whose exosporia are decorated with BclA.
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Brevibacillus laterosporus I used EM to see whether there are hair-like projections on
the spore surface of B. laterosporus. I was able to make out hair-like structures on the
entire surface of the spore, including the asymmetrical structure present at one side
(Figure 27). Western blot analysis was used to ask whether BclA is present in the outer
layer of B. laterosporus spores. The monoclonal antibody detected a >55 kDa species
(Figure 28). This suggests BclA is a spore protein in B. laterosporus 9141 and the C-
terminal domain is preserved in the BclA. It is difficult to guess which bclA-like gene is
potentially responsible for the signal as the estimated size of the BclA proteins range
from 40 to 68 kDa. We cannot exclude some glycosylation of the proteins and/or a
cleavage event before the protein was incorporated into the spore surface. I performed
IFM to answer the question whether BclA is present on the spore surface of B.
laterosporus 9141. As IFM images show, the entire surface of spores is fluorescently
labeled (Figure 29). This suggests BclA is present on the entire surface of the spores.
Paenibacillus chitinolyticus Finally, I wanted to establish whether BclA is present on
the spore surface of Paenibacillus chitinolyticus NBRC 15660. I used polyclonal anti
BclA antibody. I detected fluorescence at the poles of the spores which suggest the
location of BclA (Figure 30). I did not perform the Western analysis on P. chitinolyticus
NBRC 15660.
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Figure 14. TEM image of a B. subtilis BSn5 spore
Figure 15. Western blot analysis of spore coat proteins from B. subtilis BSn5 and B.
anthracis. Lanes 1: B. anthracis, lane 2: B. anthracis bclA, lanes 3-5: B. subtilis BSn5.
Proteins were separated on 15% (lanes 1-3) or 8% (lanes 4-5) polyacrylamide gels and
transferred to a membrane. Anti-BclA monoclonal antibody was used to detect BclA
(lanes 1-3). Serum from a mouse injected with PBS was used as a negative control (lane
4) to anti-BclA antiserum (lane 5). Antibody concentration: 1:10, 000 for anti-BclA
monoclonal antibody and 1:500 for both sera. The size of markers is given in kDa.
43
Figure 16. IFM analysis of B. subtilis BSn5 spores. Spores were fixed onto a slide and
treated with serum from mouse injected with PBS (a-c), anti-BclA antiserum (d-f) or anti-
BclA monoclonal antibody (g-i). Antibody concentration: 1:50 negative control, 1:50
anti-BclA antiserum and 1:10 000 anti-BclA monoclonal antibody.
Figure 17. TEM image of a B. amyloliquefaciens NRRL BD-553 spore.
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Figure 18. Western blot analysis of spore coat proteins from B. amyloliquefaciens strains.
Proteins were separated on 15% polyacrylamide gels and transferred to a membrane.
Anti-BclA monoclonal antibody was used to detect BclA (lanes 1-3). Anti-BclA
antiserum was used to detect BclA (lanes 4-6). Serum from a mouse injected with PBS
was used as a negative control (lanes 7-9). The figure shows B. amyloliquefaciens NRRL
BD-553 (lanes 1, 4 and 7), B. amyloliquefaciens BGSC 10A1 (lanes 2,5 and 8) and B.
amyloliquefaciens NRRL BD-599 (lanes 3, 6 and 9). Antibody concentration: anti-BclA
monoclonal antibody: 1:8,000, sera: 1:350. The size of markers is given in kDa.
A
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Figure 19. IFM analysis of B. amyloliquefaciens NRRL BD-553 and B.
amyloliquefaciens BGSC 10A1 spores. Spores were fixed onto a slide and treated with
anti-BclA antiserum (a-f), PBS serum (m-r) or anti-BclA monoclonal antibody (g-l). The
images show B. amyloliquefaciens NRRL BD-553 (a-c, g-I and m-o) and B.
amyloliquefaciens BGSC 10A1 (d-f, j-l and p-r). Antibody concentration: 1:50 anti-BclA
antiserum, 1:50 PBS serum, and 1:5 000 anti-BclA monoclonal antibody.
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Figure 20. TEM image of a B. atrophaeus 1942 spore.
Figure 21. Western blot analysis of spore coat proteins from B. atrophaeus SB512.
Proteins were separated on 15% polyacrylamide gels and transferred to a membrane.
Anti-BclA monoclonal antibody and anti-BclA antiserum were used to detect BclA (lanes
1 and 2 respectively). Serum from a mouse injected with PBS was used as a negative
control (lane 3). Monoclonal antibody concentration: 1:8000. Serum and antiserum
concentration: 1: 350. The size of markers is given in kDa
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Figure 22. Western blot analysis of spore coat proteins from B. atrophaeus 1942. Proteins
were separated on 15% polyacrylamide gels and transferred to a membrane. Anti-BclA
monoclonal antibody and anti-BclA antiserum were used to detect BclA (lanes 1 and 3
respectively). Serum from a mouse injected with PBS was used as a negative control
(lane 2). Monoclonal antibody concentration: 1:8000. Serum and antiserum
concentration: 1: 350. The size of markers is given in kDa
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Figure 23. IFM analysis of B. atrophaeus SB512 spores. Spores were fixed onto a slide
and treated with anti-BclA monoclonal antibody (a-c), serum from mouse injected with
PBS (d-f) or anti-BclA antiserum (g-i) or anti-BclA Antibody concentration: 1:50
negative control, 1:50 anti-BclA antiserum and 1:8 000 anti-BclA monoclonal antibody
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Figure 24. IFM analysis of B. atrophaeus 1942 spores. Spores were fixed onto a slide and
treated with anti-BclA monoclonal antibody (a-c), serum from mouse injected with PBS
(d-f) or anti-BclA antiserum (g-i) or anti-BclA Antibody concentration: 1:50 negative
control, 1:50 anti-BclA antiserum and 1:8 000 anti-BclA monoclonal antibody
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Figure 25. Western blot analysis of B. methylotrophicus FZB42 spore coat proteins
extraction. Proteins were separated on 15% polyacrylamide gel and transferred to a
membrane. Anti BclA monoclonal antibody was used to detect BclA. Antibody
concentration: 1: 8000. The size of markers is given in kDa.
Figure 26. IFM analysis of B. methylotrophicus FZB42 spores. Spores were fixed onto a
slide and treated with anti BclA monoclonal antibody. Antibody concentration 1:5000.
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Figure 27. TEM image of a Br. laterosporus 9141 spore.
Figure 28. Western blot analysis of B. laterosporus 9141 spore outer layer proteins
extraction. Proteins were separated on 15% polyacrylamide gel and transferred to a
membrane. Anti BclA monoclonal antibody was used to detect BclA. Antibody
concentration: 1: 8000. The size of markers is given in kDa.
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Figure 29. IFM analysis of B. laterosporus 9141 spores. Spores were fixed onto a slide
and treated with anti BclA monoclonal antibody. Antibody concentration 1:5000
Figure 30. IFM analysis of Paenibacillus chitinolyticus NBRC 15660 spores. Spores
were fixed onto a slide and treated with anti BclA monoclonal antibody. Antibody
concentration 1:100.
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Mutations in bclA Genes
Introduction BclA was detected on the spore surface of B. subtilis BSn5 and B.
atrophaeus 1942. I was also able to identify bclA candidate genes in both of the species.
We want to know whether the proteins we detect are indeed products of bclA-like gene.
Because there are multiple bclA genes in both species, I do not know which one(s)
contribute to the signal. I will inactivate each of them individually by disrupting the
corresponding gene. I decided to disrupt bclA like genes using homologous
recombination via a single cross over event (Figure 31). By integrating the plasmid into
the gene of interest, I will disrupt its function. The plasmid that I am going to use has the
spectinomycin resistance gene which will facilitate the screening process. Because the N-
terminal domain is responsible for anchoring BclA to the spore surface in B. anthracis
[24], I expect other BclA-like proteins will preserve this feature. Because I want to
establish whether BclA is a spore surface protein in other species, I will preserve the
sequence for the N-terminal domain of the native gene, and link it to the gfp gene (Figure
32). By preserving the N-terminus, followed by GFP, I will see where the protein
localizes. If the protein I detected with anti-BclA antibodies is not a product of bclA
genes, I will not detect GFP protein on the surface of spores. To complement my mutant,
I will express the wild type gene from another plasmid.
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Figure 31: bclA gene inactivation in B. subtilis BSn5 and B. atrophaeus 1942-A. Gene
inactivation by plasmid integration.
Figure 32. bclA gene inactivation in B. subtilis BSn5 and B. atrophaeus 1942-B. Gfp gene
is inserted into the pRP1028 plasmid and linked to the truncated N-terminus of bclA
gene. Plasmid will insert into the genome and disrupt the bclA gene.
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Inactivation of bclA Genes in Bacillus subtilis BSn5 I successfully built two
knockout plasmids. We decided to inactive two out of three genes in B. subtilis BSn5
(accession number ADV93334 and ADV96781). The third bclA gene has a very short N-
terminal domain (7 amino acids long) and we believed it would not suffice to localize the
protein to the spore surface. Both plasmids were sequenced to confirm a proper insertion
of bclA fragment. First, I attempted to create mutants by following the protocol for three
parental mating which involves a donor strain, a helper strain and a recipient strain. This
protocol has been successful in introducing pRP1028 into B. anthracis. No B. subtilis
colonies grew on the selective medium after the presumed conjugation. I concluded I was
not able to introduce either of the two plasmids into B. subtilis BSn5. I performed the
procedure again and this time I set up two controls: I used B. anthracis as my positive
control as I knew the protocol works for this species. I used B. subtilis PY79 which is our
lab strain. I wanted to see whether I am able to introduce pRP1028 into an organism
which is the same species as BSn5. In this round of experiments, I used an empty
pRP1028 plasmid meaning there was no bclA or gfp insert. I successfully introduced
pRP1028 into B. anthracis. Since no B. subtilis colonies grew on the selective medium, I
concluded I cannot introduce pRP1028 into either B. subtilis PY79 or BSn5 by this
technique. Additionally, I investigated whether pRP1028 was the problem and therefore I
could not insert in into B. subtilis. I used the same procedure to introduce another plasmid
into B. anthracis, B. subtilis BSn5 and PY79. pBKJ236 is the first generation plasmid
from which pRP1028 was derived. Similarly as with pRP1028, I successfully introduced
the plasmid into B. anthracis, but failed with B. subtilis BSn5 and PY79. There is a report
in the literature suggesting that passing plasmids through E. coli strains deficient in
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adenine and cytosine methylation increases the efficiently of plasmid transfer into B.
anthracis [41]. Although introducing the plasmid into B. anthracis was not an issue, I
decided to test whether I was able to introduce the demethylated pRP1028 or pBKJ236
into either B. subtilis BSn5 or PY79. Again, I did not observe any bacillus colonies in
either strain with either pRP1028 or pBKJ236.I concluded three parental mating is not a
good method to introduce either pRP1028 or pBKJ236 into B. subtilis strains. I moved on
to the eletroporation protocol. I tried to transform both B. subtilis BSn5 and PY79 with
pRP1028 and pBKJ236. Again, I was not able to create mutants. Because I started
suspecting pRP1028 is the problem per se, I chose additional two plasmids to test. I chose
pEO-3 and pIMAY as both these plasmids have temperature sensitive origin of
replication. This feature is important in my study as I try to force the plasmid into the
genome of B. subtilis BSn5. pEO-3 is used in B. anthracis studies and pIMAY is used in
S. aureus studies. I successfully introduced both of the plasmids into B. subtilis PY79.
However, I was not able to introduce either of the plasmids into B. subtilis BSn5. These
results led to the conclusion I do not have a proper protocol to introduce a plasmid into a
B. subtilis BSn5.
A study by Xue et al investigated electroporation efficiency in various media [30].
Specifically, the group investigated the presence of sorbitol and mannitol in
eletroporation, growth and recovery media and its effect on electroporation efficiency.
The group established LB +0.5 M sorbitol to be the best growth medium, LB + 0.5 M
sorbitol + 0.38 M mannitol to be the best recovery medium. The electroporation medium
contained 0.5 M mannitol and 0.5 M sorbitol. I followed our protocol with the updated
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media.  I was not successful in obtaining any B. subtilis BSn5 colonies on the selective
medium and I concluded this protocol was not suitable for my strain.
A study by Zhang et al. explored several methods of electroporation to successfully
introduce a plasmid into B. subtilis ZK [31]. The researchers claimed that two additional
steps have to be taken in order to successfully introduce a plasmid into a wild B. subtilis.
First, the cells have to be grown in medium with wall-weakening agents. Ampicillin,
glycine, threonine and Tween 80 were used in the study and showed to increase
eletroporation efficiency. Additionally, the researchers demonstrated electroporation
efficiency significantly increases when field strength is increased. They reached the
highest electroporation efficiency with the field strength of 20,000 KV/cm. The field
strength routinely used in our electroporation protocol is 12,500 KV/cm. I updated my
protocol by adding 1% threonine and 0.07% Tween 80 into my growing cells one hour
prior to the cell harvest (as stated in the article). Additionally, I increased the field
strength to 20,000 KV/cm. I did not obtain any B. subtilis colonies on the selective
medium. I concluded this protocol was not successful in introducing pRP1028 into the
cell.
My failed attempts suggest at this time we do not have a proper protocol to transform
B. subtilis BSn5. I also conclude that pRP1028 might not be the right choice for my study
as I was not able to introduce this plasmid into B. subtilis PY79 but succeeded with pEO-
3 and pIMAY.
Inactivation of bclA Genes in Bacillus atrophaeus 1942 I successfully built the
knockout plasmids. Plasmids were sequenced to confirm a proper insertion of bclA
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fragment. I followed all the procedures mentioned in the B. subtilis BSn5 section with the
same results. None of the procedures were suitable for creating the mutants.
Conclusion At this time, I do not have a clear idea why I cannot create mutants in
either B. subtilis BSn5 or B. atrophaeus 1942. I believe I do not have an appropriate
protocol for transformation of either of the species. Additionally, based on a failed
attempt to introduce pRP1028 into B. subtilis PY79, I speculate this plasmid is not
appropriate for B. subtilis group species (or at least under the conditions I tested). One of
the ways mutants are created in B. subtilis is by inducing competency in the cells.
Competent B. subtilis cells will pick up exogenous DNA (like plasmids). Recently, Zhao
et al. adapted a protocol that induces competence in B. subtilis to B. amyloliquefaciens
and succeeded in creating mutants [43]. The plasmid used in the study was pMUTIN4.
The next step in this study is to adopt Zhao’s protocol with pMUTIN4 plasmid and
attempt to introduce this plasmid into B. subtilis BSn5 and B. atrophaeus 1942.
The Effect of BclA on Spore Surface Properties
Measuring Hydrophobicity of Spores The effect of BclA on spore surface properties
in not known. We wanted to establish whether lack of BclA on the spore surface will
cause changes in spore surface properties such as hydrophobicity. Studies by Brahmbhatt
et al. show spores are less hydrophobic when BclA is absent [16]. If spores are treated
with heat beforehand, bclA spores become more hydrophobic but the heat treatment has
little effect on the hydrophobicity of the wild type spores. First of all, I wanted to
establish whether I can get similar result to the published one when I use our B. anthracis
wild type spores and bclA spores. First, I investigated whether the amount of hexadecane
has an effect on the hydrophobicity of the spores. I mixed spore suspensions with three
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different amounts of hexadecane and calculated the hydrophobicity of wild type and bclA
spores.  My results show that no matter the amount of hexadecane, both the wild type and
bclA spores gave similar results (Figure 33).  The hydrophobicity values range from 79%
to 91% for wild type spores and 81% to 92% for the bclA spores. These results tell us
both BclA-positive and BclA-negative spores are equally hydrophobic. Under my
conditions, I was not able to detect differences in the spore surface properties in B.
anthracis spores. Because it has been shown that heat treatment has an effect on spore
hydrophobicity of bclA mutants I asked if heat treatment changes hydrophobicity of my
spores. I pretreated the spores with various temperatures (37, 65 and 100 °C) prior to the
BATH assay. I found heat treatment at 65 and 100 °C slightly decreased wild type spore
hydrophobicity. There was also a slight decrease in hydrophobicity in bclA mutant spores
when prior heat of 65 and 100 °C was applied. Overall, the spores of both strains had
similar hydrophobicity and I concluded that heat treatment does not cause noticeable
changes to the spore surface hydrophobicity (Figure 34).
I examined if various amount of hexadecane have an effect on spore hydrophobicity in
B. subtilis BSn5 and B. atrophaeus 1942.  Similar to the B. anthracis assay, I mixed
spore suspensions with three different amounts of hexadecane and calculated the
hydrophobicity of the spores. Because I did not create bclA mutants in either B. subtilis
BSn5 or B. atrophaeus 1942, I was only able to evaluate the hydrophobicity of the wild
type spores. The percent of hydrophobicity increase with the increase amount of
hexadecane added to the spore suspension of B. subtilis Bsn5 (Figure 35). The values
ranged from 40 to 80%. There was only a slight increase in hydrophobicity of B.
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atrophaeus 1942 in response to increase in hexadecane concentration. I concluded B.
atrophaeus 1942 spores are less hydrophobic than spores of B. subtilis BSn5.
Measuring Clumping of Spores A study on B. subtilis lacking polysaccharides on
the spore surface shows spores clump more readily than the wild type [35]. BclA is a
highly glycosylated protein and therefore I expected spores lacking BclA to clump faster.
I asked whether lack of BclA on the spore surface would cause spores to clump. To
answer this question I performed a clumping assay where the change in OD over-time
should reflected the rate at which the spores clump. I performed the assay with B.
anthracis wild type and bclA mutant spores at the same time. Wild type served as my
positive control of how fast spores clump when BclA is present. There were no striking
differences in the OD change (Figure 36). Wild type spores clumped at almost identical
rate and the final OD was 91% and 93% of the starting one meaning within 90 minutes of
the assay only 9% and 7% of spores clumped. The final OD reading for bclA mutant
spores was 98% and 87% meaning within 90 minutes 2% and 13% of spores clumped,
respectively. These data suggest spores of both strains clump at a similar rate.
I asked whether there is a difference in clumping rate in B. subtilis BSn5 and B.
atrophaeus 1942. I performed the same assay mentioned above. The final OD reading
was 95% of the starting OD for B. atrophaeus meaning only 5% clump in 90 minutes
(Figure 37). The final OD reading was 96% of the starting OD for B. subtilis meaning
only 4% clump in 90 minutes. I concluded spores of B. subtilis BSn5 and B. atrophaeus
1942 clump at a similar rate. The results were similar to wild type and bclA spores of B.
anthracis.
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Conclusion Based on my results, I conclude spores of B. anthracis with and without
BclA on their surface are similarly hydrophobic. Moreover, the hydrophobicity does not
change with heat treatment. My findings suggest the lack of BclA does not affect the
spore surface hydrophobicity. My results are different from the published results. The
discrepancy could come from a different spore preparation. Brahmbhatt et al. used
modified G medium to make the spores and purified them through a Hypaque-76 gradient
prior to the experiment. I used DMS medium and my spores did not require prior
purification. An alternative explanation for the data inconsistency is my experiment
failed.
I showed the spores of B. anthracis with or without BclA clump at the same rate.
Because the clumping effect was shown to be due to the lack of sugars on the spore
surface of B. subtilis, I conclude the sugars present on BclA are not sufficient to change
the clumping dynamics of spores lacking BclA. Alternately, spores lacking BclA might
still be glycosylated to the same extent as the wild type by some alternative mechanism.
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Figure 33. Measuring hydrophobicity of B. anthracis spores. Spores with or without
BclA were mixed with various amount of hexadecane and the change in the OD440 of the
spore suspension was used as readout for the hydrophobicity.
Figure 34. Measuring hydrophobicity of B. anthracis spores. Spores with or without
BclA were pretreated with heat and incubated overnight. Next day, spores were mixed
with the hexadecane and the change in the OD440 of the spore suspension was used as
readout for the hydrophobicity.
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Figure 35. Measuring hydrophobicity of B. subtilis BSn5 and B. atrophaeus 1942 spores.
Spores were mixed with various amount of hexadecane and the change in the OD440 of
the spore suspension was used as readout for the hydrophobicity.
Figure 36. Clumping assay of WT and bclA spores of B. anthracis. Spores were
vigorously shaken and the change in OD was measured every 10 minutes.
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Figure 37. Clumping assay of B. subtilis BSn5 and B. atrophaeus 1942 spores. Spores
were vigorously shaken and the change in OD was measured every 10 minutes.
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CHAPTER FOUR
DISCUSSION
Until recently, BclA was only thought to be a protein present on the spore surface of
B. anthracis and its close relatives. In 2014, Pizarro-Guajardo et al. published a
surprising finding that BclA is a spore surface protein in C. difficile [36]. This was a
remarkable discovery as the spores of C. difficile do not possess exosporia. Furthermore,
C. difficile is not remotely related to the B. cereus group as it belongs to a different class
of bacteria, called Clostridia. This discovery led to our hypothesis that BclA is a common
spore surface protein.
bclA Gene
My genomic analysis revealed that bclA-like genes are widely present in the genomes
of spore-forming bacteria. bclA-like genes are found in genomes of species from
Bacillaceae, Paenibacillaceae, and Clostridiaceae. Surprisingly, there are multiple bclA-
like genes that can be found in each species and the number of genes varies even across
the strains. We discovered the B. subtilis PY79 strain that is routinely used in the lab,
does not have bclA-like genes in its genome. Previously, we tried to find BclA on the
spore surface of that species and we failed. It would be interesting to determine which
strains of spore-forming bacteria do have bclA gene and which do not. An ideal approach
would be to focus on a group of fully sequenced species and strains to establish which
strains have genes homologous to bclA. By building a phylogenetic tree and establishing
which strains do have bclA we could trace the loss of the gene. It would be important to
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know where the strains have been isolated from to pinpoint an environmental factor that
drives the the preservation of bclA.
BclA Domain Organization
BclA in B. anthracis has three domains: N-terminal domain, collagen-like region and
C-terminal domain. Based on the amino acid analysis, I conclude that the domains of
BclA are preserved in other spore-forming bacteria. The greatest variation is found in the
N-terminal domain of BclA. It may be as short as 2 amino acids and as long as 240 amino
acids. We know from the C. difficile study, that the N-terminal domain as short as 5
amino acids is sufficient to localize the protein to the spore surface [36]. The collagen-
like region varies in its length but the unifying feature is an abundance of GXT triplets.
This feature might be the hallmark of spore-associated collagen-like proteins. There are
other collagen-like proteins in nature; some of them are present in human pathogens.
Streptococcal collagen-like (Scl) protein is present at the surface of Streptococcus
pyogenes cells [37]. Lack of Scl on the cell surface decreases the adherence of the cells to
human fibroblast. Additionally, when scl S. pyogenes is injected subcutaneously into
mice, the virulence is attenuated. Another collagen-like protein, Lcl, is found in
Legionella pneumophilia [38]. Cell lacking Lcl are deficient in autoaggregation.
Interestingly, both Scl and Lcl are rich in GXX triples but rarely is there a GXT triple
(BLAST). More work is needed to establish if the difference in the collagen triplets
composition is a good way of distinguishing between bacterial protein and spore surface
collagen-like proteins. Finally, the C-terminal domain of BclA ranges from 130 to 160
amino acids. Based on BLAST analysis, the sequence of C-terminal domain is mostly
preserved in B. cereus group, and there is some amino acid preservation in other species.
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It would be interesting to solve the three dimensional structure of the C-terminal domain
for some nonpathogenic spore-forming bacteria. We know that in BclA of B. anthracis,
the C-terminal domain resembles the C1q. Do the C-terminal domains of nonpathogenic
species have the C1q resemblance or are they completely different in their structure? If
the domains are similar, could they also activate the classical complement pathway as in
the case of B. anthracis BclA?
Localization of BclA
BclA in B. anthracis is present on the entire surface of the spore. In our study, BclA
distribution was not uniform. I learned BclA is only localized at the poles of B.
atrophaeus 1942, B. methylotrophicus FZB42 and P. chitinolyticus NBRC 15660. The
simple explanation is BclA is only present at the poles of spores of these three species.
Alternatively, BclA might actually be present on the entire spore surface but might be
occluded by other proteins. If indeed BclA is only present at the poles of the protein,
what is the significance of this localization? Is this localization dictated by the
environmental pressure?
BclA was localized on the entire surface of Br. laterosporus 9141, B.
amyloliquefaciens NRRL BD-553 and B. subtilis BSn5. Interestingly, only a subset of
spores of B. subtilis had BclA on their spore surface. I wonder whether bclA-like genes in
B. subtilis BSn5 are flanked by phage-like regions could explain this variation in protein
distribution. We know from B. subtilis literature that there are prophage regions in the
genome that excise during sporulation. An example of this phenomenon is the excision of
the skin element that disrupts the sigK gene which codes for sigma K [39]. Another
example is the SP beta prophage which excises from a sporulating cells and reconstitutes
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a polysaccharide synthesis gene, spsM [40]. Further studies are needed to evaluate
whether the phage elements are responsible for BclA variation in B. subtilis BSn5.
BclA Function
The function of BclA is still unknown. There have been studies suggesting BclA has a
role in the infection process as it interacts with the complement system [14]. This
prompts the question of why is B. anthracis BclA capable of interacting with the immune
system. Precisely, how is BclA of B. anthracis different from BclA of other
nonpathogenic species? If BclA has a role in the soil environment, is it possible B.
anthracis BclA is multifunctional where is has both a purpose in the soil as well as in
host and microbe interaction? There are many questions that need to be asked and
comprehensive studies to be performed before one can say what the function of BclA is.
Mutations in Wild Spore-Forming Species
In this study, I attempted to create bclA mutants in B. subtilis BSn5 and B. atrophaeus
1942. There are multiple ways one can introduce exogenous DNA into B. subtilis: by
natural transformation, phage transduction, electroporation and protoplast. In this study, I
mainly focused on electroporation as it is easy to perform. Although I explored multiple
protocols, none of them seemed to be suitable for the strains I wanted to mutate. Multiple
studies have been done to address manipulation of wild spore-forming bacteria. Most of
them point out that each species might require customized protocols for transformation.
Kolek et al. showed that well established protocols for C. difficile and C. cellulolyticum
were not suitable to transform C. pasteurianum [41]. The group recognized the major
obstacle of their study was the methylation status of plasmids they used. Only after the
plasmid was passed through an E.coli strain deficient in dam and dcm genes, was the
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group able to transform C. pasteurianum with a modified protocol. The methylation issue
was addressed in my study. I passed pRP1028 through a dam dcm deficient E.coli but this
did not allow me to transform either B. subtilis or B. atrophaeus. Interestingly, what my
study revealed is pRP1028 might not be a suitable plasmid to transform B. subtilis-like
species, at least under our lab conditions. This conclusion was made based on the ability
to introduce two different plasmids (pIMAY and PEO-3) into B. subtilis PY79, our lab
strain, but not pRO1028. I demonstrated the electroporation protocol routinely used is
suitable for B. subtilis PY79 but not for B. subtilis BSn5 or B. atrophaeus 1942. The
study by Zhang et al. explores multiple factors affecting electroporation efficiency. The
group shows that the pretreatment of cells with cell-wall weakening agents and an
increase in electric field increase the electroporation efficiency in B. subtilis ZK. In my
study these two additional steps were not sufficient to allow plasmid uptake. I conclude
that B. subtilis BSn5 as well as B. atrophaeus 1942 need customized protocols for an
efficient transformation. Although in this study, I only tried to mutate the strains through
conjugation and electroporation, there are other methods that were not explored. An
induction of competence is another way to mutate B. subtilis [42]. Recently, Zhao et al.
were able to mutate B. amyloliquefaciens by adopting a B. subtilis protocol [43]. Because
B. amyloliquefaciens is closely related to B. subtilis, it is plausible to think, the same
protocol could work for B. subtilis and B. atrophaeus. An alternative way to mutate wild
isolates is to use a newer technique that recently emerged. CRISPR/Cas9 method might
be the answer to manipulating wild species that do not subject to lab protocols. CRISPR-
based genome engineering has been mostly done in eukaryotic cells. Recently, the
CRISP/Cas9 system has been successfully used to mutate genes in Streptococcus
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pneumoniae and E. coli [44]. In the future, the CRISPR system should be tried on the
wild spore-forming organisms in other to mutate bclA gene. This mutation would prove
what is detected on the spore surface of various species is indeed BclA and it would also
facilitate studies addressing the question of BclA’s function.
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CHAPTER FIVE
P5303
Introduction
Anthrax is a disease caused by a spore-forming bacterium, B. anthracis. Anthrax can
be acquired by three routes: by inhalation, through a skin lesion, or by ingestion.
Ingestion is the natural route of B. anthracis infection in grazing animals [46]. Humans
can be exposed to B. anthracis usually by working with infected animals. Cutaneous
infection is predominant and is often a result of open skin contact with the sick animal.
Gastrointestinal infection can result from eating contaminated meat. Inhalational anthrax
is a result of breathing in spores usually by working with wool, hides or hair coming from
the sick animal. Inhalation of B. anthracis spores may result in the most severe disease
outcome [47]. The pulmonary and gastrointestinal anthrax are of great concern as the
disease symptoms are nonspecific. When anthrax is caught in its early stages, it is
treatable. In some cases it is difficult to diagnose anthrax; it is important to focus on
preventive measures at least for a population that is at highest risk of B. anthracis
exposure. One preventive measure used is a vaccine. There are indeed two anthrax
vaccines approved for humans: human anthrax vaccine adsorbed (AVA) and human
anthrax vaccine precipitated (AVP). The protection of AVA vaccine comes mainly from
a single protein, protective antigen (PA).
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PA is the cell binding component of both edema and lethal toxins [48]. PA protein is
produced after a spore germinates which means the vaccine targets a later stage of
infection. More recent approaches target an early stage of anthrax infection – the
acquisition of spores. Therefore the current vaccines studies are focused on adding spore
surface proteins to the vaccines [49, 50]. There are 30 proteins that are localized to the
exosporium of B. anthracis [49]. One of the proteins is P5303. P5303 has already been
used in vaccine studies. Cybulski et al. showed anti spore antiserum recognizes a
recombinant P5303 and therefore it is believed P5303 is a spore protein. However, there
is no published study that shows P5303 is a spore surface protein. Moreover, we do not
know the localization of the protein within the exosporium. As P5303 is a promising
candidate for a vaccine, it is important to establish where the protein is present, what
effects does it have on the spore morphology, and what is its function.
Methods
Spore Preparation Spores were prepared by exhaustion in Difco Sporulation
Medium (DSM) [28]. A single colony was picked from a Luria Broth (LB) plate and
suspended in 200 µl of DSM. The bacterial suspension was spread onto a DSM plate and
incubated at 37 °C for 8 to 9 hours. After the incubation period, the lawn was collected
by suspension in 5 ml of DSM. 1 ml of the lawn was transferred into the 35 ml of DSM
in a 250 ml flask. The flask was shaken at 225 rpm at 37 °C overnight. The next day, 5 µl
of the sample was placed onto a glass slide and the sample was checked for the presence
of spores under the phase-contrast microscope. The spores were spun down and the
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pellets were washed 3 times with MQ water. The spores were stored in water in a 50 ml
tube at 4°C.
Creation of B. anthracis Mutant p5303 was deleted by following a protocol
published by Warrens et al. [51]. Upstream and downstream regions of p5303 gene were
amplified (Primers 1and 2 for upstream region, Primers 3 and 4 for downstream region)
and fused by splicing using overlap extension PCR. The fused fragment was cut with
HindIII and BamHI and ligated into pGEM-T plasmid. pGEM-T was transformed into E.
coli DH5α. pGEMT was isolated with a kit (Thermofisher). The plasmid was digested
with HindIII and BamHI. DNA was separated on a 1% agarose and the upstream-
downstream region was cut out and purified. The fragment was ligated into a pRP1028
plasmid. pRP1028 was then transformed into E. coli DH5α.
Plasmids were introduced into bacterial cells by conjugation [29]. On day 1, the donor
strain, the recipient strain and the helper strain were struck out onto LB +100 µg/ml
spectinomycin, BHI and LB +100 µg/ml ampicillin, respectively. The donor strain
contained the allelic exchange construct cloned into pRP1028. The recipient strain was B.
anthracis. Plates were incubated at 37°C overnight. On day 2, each strain was scraped off
the plate, plated onto a BHI plate and mixed together. The BHI plate was incubated at the
room temperature. On day 3, the mixed strains were streaked out onto a selective plate
that contained BHI + 250 µg/ml spectinomycin + 60 units/ml polymixin B. The plate was
left at the room temperature for 24 hours. B. anthracis colonies were picked and
restreaked for isolation two times. On day 6, the helper strain and strain containing
facilitator plasmid were struck out onto LB-amp and LB-kan (20 µg/ml kanamycin),
respectively. On day 7, three strains were mixed together on a BHI plate and incubated at
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37°C for 8 hours. Later that day, the mixture was scraped off and streaked out on a BHI-
KanPmx plate (BHI + 20 µg/ml kanamycin + 60 units/ml polymixin B). The plate was
incubated at 37°C overnight. On day 8, B. anthracis colonies were picked and restreaked
for isolation. Colonies were patched onto the BHI-SpecPmx and the BHI-KanPmx plates
and incubated at 37°C overnight. Spectinomycin sensitive colonies were picked and PCR
was done to confirm the gene deletion.
Spore Surface Protein Extraction and Western Blot 50 ml of spores was pelleted
down and resuspended in 10 ml of water. 5 µl of spore suspension was mixed with 495 µl
of water and OD600 was recorded. The formula 0.037/ OD600 was used to estimate the
amount of spore suspension needed for each well. The appropriate amount of spore
suspension was pelleted for 5 min/6000 rpm and the supernatant was removed. 13 µl of
Laemmli buffer (0.63 ml 1M Tris pH 6.8, 1 ml 100% glycerol, 2ml 10% SDS and 6.37
ml MQ water) and 1.5 µl of 1M DTT were added to the pellets. Samples were vigorously
shaken for 1 minute and spun down for 2 seconds. Samples were boiled for 5 minutes at
100 °C. Samples were vigorously shaken again for 45 seconds and boiled at 100°C for an
additional 5 minutes. Samples were vigorously shaken for 30 seconds and spun down for
5 minutes at 13000 rpm. The supernatants were collected and the protein concentration
was measured with Nanodrop. Proteins were resolved on 15% SDS-PAGE (10% 29:1
acrylamide: N, N’-methylene-bis-acrylamide, 375 mM Tris pH 8.6, 0.1% SDS), and
transferred to polyvinylidene difluoride membranes or nitrocellulose membranes [29].
The membranes were incubated with 2% bovine serum albumin (BSA), washed three
times with Tris-buffered saline with Tween 20 (1x TBST: 1.21 g Tris, 8.76 g NaCl,
0.05% Tween 20 in 1L of water) then incubated with anti-P5303 polyclonal antibody
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(BEI Resources). Goat anti rabbit IgG was used as the secondary antibody (Sigma).
Immunofluorescence Microscopy 10 µl of culture was placed into each well of a
multiwell slide. The slides were pretreated with 0.01% (wt/vol) poly-L-lysine, washed
twice with water and air-dried. 10 µl of phosphate-buffered saline (PBS) was then placed
into each well and was replaced with 2% (wt/vol) BSA in phosphate-buffered saline prior
to the addition of primary antibody. Anti-P5303 antibody was used at 1:300 dilutions.
Secondary antibody was used at a 1:300 dilution. Alexa Fluor 594 goat anti rabbit IgG
was used as the secondary antibody (Molecular probes, Life Technologies TM ).
Electron Microscopy A pellet from 1 ml of the p5303 mutant spore stock was
prepared. The pellet was mixed with 840 µl of 10mM phosphate buffer (pH 7) and 160 µl
of 8% gluteraldehyde. The sample was incubated overnight at 4 °C. The next day, the
sample was spun down and washed in 1 ml of 0.5 M NH4Cl twice. The pellet was mixed
with 300 µl 10mM phosphate buffer (pH 7) and 100 µl of 4% osmium tetraoxide. The
pellet was incubated overnight at 4 °C. The next day, the pellet was washed twice with
1ml of 0.5 M NH4Cl and resuspended in 100 µl of water. 300 µl of 3% melted agarose
was mixed with the spore pellet and transferred onto an agarose cushion. The sample was
spun down for 30 seconds. After the sample solidified, the pellet was cut with a razor
blade into small pieces and placed into a scintillation vial. The sample was subjected to
dehydration steps in 4 ml of 30%, 50%, 70% and 100% ethanol with rocking for 1 hour
in-between. Next, the samples were mixed with 1:1 mixture of 100% ethanol and resin,
followed by 100% resin. The sample in resin was left rocking overnight at room
temperature. The next day, the samples were fished out and placed into a resin mold.
Fresh resin was poured onto the sample and the sample was left baking overnight.
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Species/strains Genotype or description Reference or source
B. anthracis 34F2 Wild type Laboratory collection
B. anthracis 34F2 pXO1+ pXO2- bclA::kan Laboratory collection
B. anthracis 34F2 ΔbclA Laboratory collection
E. coli DH5α Cloning host Laboratory collection
E. coli SS4332 Facilitator strain Stibitz and Carbonetti
1994
E. coli SS1827 Helper strain Stibitz and Carbonetti
1994
Plasmids Description Reference
pGEM-T Cloning vector Promega
pRP1028 Temperature sensitive vector in
Gram positive bacteria, SpecR
Plaut & Stibitz 2015
Table 7. List of strains and plasmids used in P5303 study.
Primer name Sequence (5’ -3’) #
BAS5303-Up-FW-
HindIII
ttt ttt AAG CTT TAC AAA ACC ACC CTA GAC C 1
BAS5303-Up-Rev TAG AGA AAA GAA CCT AAA TAT CAG ACC TTT CTA ATT
TAA TAT G
2
BAS5303-Dw-Fw AAG GTC TGA TAT TTA GGT TCT TTT CTC TAT TCT CAA 3
BAS5303-Dw-Rev-
BamHI
ttt ttt GGA TCC CGT ATG GAC AAA CAA AAT TAA 4
BAS5303-Up-Rev-Seq GTT ATA TAA ATT GAG AAT AGA GAA AAG AAC CT 5
BAS5303-Dw-Fw-Seq GTA CAA TCA TAT TAA ATT AGA AAG GTC TGA TAT TT 6
BAS5303-Rev-PCR-
Screeen
TGA CAA ATC CGT ATG GAC AAA C 7
BAS-Fw-PCR-Screen CCA TAT AAA ATA AAG CAA TAA TTG CTA CC 8
Table 8. List of primers used in P5303 study.
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Results
Previously, a Western blot analysis on wild type spore surface proteins has been
performed to establish the electrophoretic pattern on P5303 migration. Multiple
molecular weight species were detected with the polyclonal antibody. Having a clean
mutation in the p5303 gene, enabled us to exclude the non-specific bands from the
genuine P5303 signal via Western blot. To determine which of the proteins detected by
the polyclonal antibody is P5303 I performed a Western blot both with wild type B.
anthracis and p5303 strain. Three molecular species were detected in the p5303 mutant
(Figure 38). I concluded those particular bands were non specific bands. A single band
migrating at <15kDa was absent from p5303 mutant. I believe this is the monomeric form
of P5303 protein. Additionally, high molecular weight species were only detected in the
wild type spores. This suggests P5303 is present in protein complexes that are resistant to
DTT-SDS treatment. Next, I wanted to know whether P5303 is a spore surface protein.
To find out whether P5303 is present on the surface of B. anthracis spores, I performed
IFM. Anti-P5303 polyclonal antibody did not detect proteins on the surface of wild type
B. anthracis spores (Figure 39). As expected, the antibody did not bind to any proteins on
the surface of B. anthracis lacking P5303. Cybulski et al. suggested P5303 is a basal
layer protein located beneath BclA [49]. I questioned whether BclA occludes the epitopes
to which our antibody binds and hence we cannot detect P5303 on the wild type spores. I
performed IFM on spores that lack BclA on their surface. Interestingly, I detected
fluorescence in bclA mutant spores (Figure 40). The ring of fluorescence surrounded the
entire spore. This suggests P5303 is indeed a spore surface protein. However, the protein
is undetectable in wild type spores possibly due to BclA presence. This result could also
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suggest that in absence of BclA the proteins in the exosporium are arranged differently
leaving P5303 accessible to the antibodies. Next, I wanted to know whether the lack of
P5303 has an effect on the spore structure. To answer this question, I performed EM.
Spores of P5303 looked indistinguishable from the spores of wild type B. anthracis
(Figure 41). This suggests P5303 does not have a role in the assembly of B. anthracis
spore that can be easily detected.
Conclusion and Future Direction
P5303 protein is an anthrax vaccine candidate. Previously, it has been shown P5303 is
a spore protein to which anti spore antiserum reacts. At that time, we did not know
exactly where the protein resides or what its role is. Additionally, we still do not
understand why the addition of this protein to the vaccine preparation makes the vaccine
work better. In this study, I was able to show P5303 can be extracted from the spore both
as a monomer as well as in a high molecular complex that resist the DTT-SDS treatment.
Moreover, my IFM study shown P5303 is indeed a spore surface protein. Its detection is
inhibited by the presence of BclA on the spore surface. In spores lacking BclA, we can
detect P5303 on the entire spore surface. We can conclude from this observation at least,
P5303 is not BclA dependent. What I was able to demonstrate is lack of P5303 does not
alter the spore structure. If it does, it is not detectable under EM. Further studies should
be done on the p5303 mutant. One of the questions that should be addressed is when does
P5303 appears on the spore surface? This could be answered by a time course
experiment. Additionally, we could investigate whether lack of P5303 on the spore
surface affects spore germination. We should also explore whether lack of P5303 makes
the spore less resistant. This could be addressed by performing toluene sensitivity assay
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and lysozyme sensitivity assay.
Figure 38. Western blot analysis of spore proteins from wild type B. anthracis and p5303
mutant spores. Proteins were separated on 15% polyacrylamide gel and transferred to a
membrane. Anti-P5303 polyclonal antibody was used to detect P5303. Antibody
concentration: 1:5000. The size of markers is given in kDa
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Figure 39. IFM analysis of wild type B. anthracis and p5303 mutant spores. Spores were
fixed onto a slide and treated with anti-P5303 antibody. Antibody concentration: 1:300
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Figure 40. IFM analysis of bclA B. anthracis spores. Spores were fixed onto a slide and
treated with anti-P5303 antibody. Antibody concentration: 1:300
82
Figure 41. TEM images of wild type and p5303 B. anthracis spores. Left: p5303 mutant
spore. Right: wild type spore (image provided by T. Boone)
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